Examination and observation for other reasons

Z21_EXAM_OBSER_OTH_REASO

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — Z04 Cause of death: ICD-10 — Z04 2 out of 7 registries used, show all original rules.	41354
4. Check minimum number of events None	41354
5. Include endpoints None	41354
6. Filter based on genotype QC (FinnGen only)	41354

Control definitions (FinnGen only)

Control exclude: Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_EXAM_INVES

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: Z[0-1]

NAME	Z21_EXAM_OBSER_OTH_REASO
CONTROL_EXCLUDE	Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_EXAM_INVES
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	Z04
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	Z04
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Examination and observation for other reasons based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	41354	26192	15162
Unadjusted period prevalence (%)	8.11	8.93	6.68
Median age at first event (years)	53.86	51.29	58.29

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
19847: Matched controls
139772

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

SAA01

NOMESCO Finland

Simple examination of mouth

1.9

323.0

12658

67845

B01AB05

ATC

enoxaparin; parenteral

2.2

323.0

4989

18212

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

59.7

323.0

853

105

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

46.0

323.0

1164

189

H02AB06

ATC

prednisolone; systemic

2.0

323.0

7811

34319

Z01.8

ICD-10 Finland

Other specified special examinations

12.3

323.0

3585

2461

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

101.3

323.0

3725

318

R42

ICD-10 Finland

Dizziness and giddiness

2.4

323.0

3290

10561

N03AX16

ATC

pregabalin; oral

2.8

323.0

4111

11769

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.9

323.0

6962

21796

UJF30

NOMESCO Finland

Ileoscopy through colon

5.0

323.0

2143

3324

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.9

323.0

2598

6914

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.3

323.0

7893

31231

N05AH04

ATC

quetiapine; oral

2.9

323.0

3264

8970

P01AB01

ATC

metronidazole; oral, rectal

2.0

323.0

5986

25094

Z04.3

ICD-10 Finland

Examination and observation following other accident

678.1

323.0

2151

A02BC02

ATC

pantoprazole; systemic

2.6

323.0

11901

51233

N05BA04

ATC

oxazepam; oral

2.3

323.0

3983

13783

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

16.6

323.0

4272

2269

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.2

323.0

5418

20070

ZX120

NOMESCO Finland

Intravenous

3.5

323.0

1779

3833

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.0

323.0

8074

36137

Z01.0

ICD-10 Finland

Examination of eyes and vision

20.1

323.0

2420

956

S18

ICPC

Laceration/cut

2.1

323.0

7177

29642

Z01.1

ICD-10 Finland

Examination of ears and hearing

8.2

323.0

1743

1629

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

6.0

323.0

7836

13657

Z04.0

ICD-10 Finland

Blood-alcohol and blood-drug test

657.3

323.0

367

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.9

323.0

2830

7477

R53

ICD-10 Finland

Malaise and fatigue

2.4

323.0

3505

11474

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

345.6

323.0

13685

892

R06.0

ICD-10 Finland

Dyspnoea

2.4

323.0

4019

13193

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

104.4

323.0

618

R51.80

ICD-10 Finland

Headache

3.1

323.0

2581

6497

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

36.6

323.0

1204

246

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

57.7

323.0

2078

283

N02AX02

ATC

tramadol; systemic, rectal

2.3

323.0

7863

31025

M79.6

ICD-10 Finland

Pain in limb

2.3

323.0

5986

22066

Z00.0

ICD-10 Finland

General medical examination

3.4

323.0

2766

6355

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.8

323.0

3537

10058

Z04.4

ICD-10 Finland

Examination and observation following alleged rape and seduction

869.5

323.0

364

A02BC03

ATC

lansoprazole; oral

2.1

323.0

4645

17574

N02AJ06

ATC

codeine and paracetamol; systemic

1.9

323.0

6497

28179

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

549.3

323.0

1382

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

124.8

323.0

635

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

8.8

323.0

2260

2003

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.9

323.0

7151

31781

R07.4

ICD-10 Finland

Chest pain, unspecified

2.4

323.0

4587

15429

WX110

NOMESCO Finland

Local anesthesy

1.8

323.0

12495

67305

N06AX11

ATC

mirtazapine; oral

2.3

323.0

5469

19619

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.4

323.0

4154

13762

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.2

323.0

2311

5482

UJF32

NOMESCO Finland

Coloscopy

4.8

323.0

6329

12468

M54.5

ICD-10 Finland

Low back pain

2.2

323.0

5732

21533

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

42.3

323.0

1134

200

N02BE01

ATC

paracetamol; systemic, rectal

2.8

323.0

16119

84328

J01DB01

ATC

cefalexin; oral

2.4

323.0

15627

84478

A02BC05

ATC

esomeprazole; systemic

2.2

323.0

6804

27020

M25.5

ICD-10 Finland

Pain in joint

2.3

323.0

4653

16430

R03AC02

ATC

salbutamol; inhalant

1.8

320.9

8598

41233

UJF92

NOMESCO Finland

Capsular endoscopy

11.6

314.0

657

412

N05CF01

ATC

zopiclone; oral

2.0

312.1

5075

20225

J01MA02

ATC

ciprofloxacin; systemic

1.9

309.3

6647

29426

N03AX12

ATC

gabapentin; oral

2.8

306.6

2397

6634

ZXA00

NOMESCO Finland

Right side

2.1

306.6

4472

17017

X58

ICD-10 Finland

Exposure to other specified factors

2.5

298.3

2910

9129

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.8

296.6

9456

47537

XQ800

NOMESCO Finland

Prick test

5.0

296.4

1081

1589

A06AC01

ATC

ispaghula (psylla seeds); oral

2.3

296.3

3477

11972

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.8

295.5

7616

35736

WX408

NOMESCO Finland

General anesthesy, balanced

2.0

294.9

4666

18318

J01CA04

ATC

amoxicillin; systemic

1.8

293.4

14805

85910

L17

ICPC

Foot/toe symptom/complaint

2.1

289.7

3890

14230

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

3.7

289.1

1468

2973

AA1AD

NOMESCO Finland

CT of head and brain

2.2

288.2

3839

13991

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

3.6

287.1

1513

3159

C07AB07

ATC

bisoprolol; oral

1.8

284.7

7340

34319

Z04.1

ICD-10 Finland

Examination and observation following transport accident

100.9

282.4

352

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.3

279.0

3106

10392

SAA03

NOMESCO Finland

Extended examination of mouth

1.8

277.4

6728

30757

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.4

276.1

2888

9363

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.3

274.8

3240

11136

X59

ICD-10 Finland

Exposure to unspecified factor

2.2

274.8

3564

12801

N06AB10

ATC

escitalopram; oral

2.2

272.6

3314

11552

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

36.2

272.0

394

ZXA05

NOMESCO Finland

Left side

2.0

270.4

4112

15799

R4110

NOMESCO Finland

Physiotherapy

2.0

269.1

4518

18056

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.8

267.8

2000

5350

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

3.1

266.9

1731

4216

T36

ICD-10 Finland

Poisoning by systemic antibiotics

5.0

265.4

965

1411

N06AX16

ATC

venlafaxine; oral

2.7

264.5

2168

6138

L03

ICPC

Low back symptom/complaint

2.1

263.9

3573

13051

A29

ICPC

General symptom/complaint other

2.8

262.8

1919

5059

J01AA02

ATC

doxycycline; systemic

1.7

261.4

12990

73335

XA402

NOMESCO Finland

ENMG

14.5

259.9

492

244

M03BX02

ATC

tizanidine; oral

1.7

258.3

10213

53855

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.7

258.0

8254

40901

A04

ICPC

Weakness/tiredness general

2.6

256.3

2137

6105

L28

ICPC

Limited function/disability (L)

2.5

254.4

2290

6832

J45.9

ICD-10 Finland

Asthma, unspecified

2.4

250.5

2643

8569

SAA02

NOMESCO Finland

Basic examination of mouth

1.7

249.2

11257

61375

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.4

249.2

2451

7666

TPH04

NOMESCO Finland

Cathetrisation of vein

2.1

248.2

3529

13123

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.9

246.5

1769

4602

Z71.8

ICD-10 Finland

Other specified counselling

2.1

244.8

3631

13734

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.9

242.6

4778

20133

S29

ICPC

Skin symptom/complaint other

2.3

241.0

2687

8939

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.3

240.3

2782

9424

K02.1

ICD-10 Finland

Caries of dentine

1.7

240.2

10085

53619

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

3.0

239.5

1560

3801

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

3.0

239.4

1612

4018

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.8

238.0

1809

4876

J02AC01

ATC

fluconazole; systemic

1.9

237.0

4753

20128

M54.4

ICD-10 Finland

Lumbago with sciatica

2.3

236.9

2514

8159

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.7

236.0

8721

44656

N06AB04

ATC

citalopram; systemic

2.1

233.1

3135

11352

WZA90

NOMESCO Finland

Other doctors statement

2.0

230.1

3942

15735

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.6

229.3

9099

47384

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

3.1

228.8

1479

3580

R50.9

ICD-10 Finland

Fever, unspecified

2.3

228.4

2513

8291

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

2.0

227.7

3437

13045

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.9

227.5

3972

15959

J01FF01

ATC

clindamycin; systemic

1.9

227.3

4454

18661

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.1

227.1

3090

11229

E0000UV

ATC

1.7

226.6

6208

29029

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.4

225.6

1274

2792

XQ802

NOMESCO Finland

Epicutan test

8.1

221.9

561

500

A02BC01

ATC

omeprazole; systemic

1.9

221.3

4281

17829

L30.9

ICD-10 Finland

Dermatitis, unspecified

2.2

219.6

2682

9281

N06AX21

ATC

duloxetine; oral

2.9

218.8

1538

3934

G44.2

ICD-10 Finland

Tension-type headache

2.6

218.5

1862

5360

K30

ICD-10 Finland

Functional dyspepsia

2.9

218.0

1560

4038

WX002

NOMESCO Finland

Sedation and analgesia

2.1

217.3

3083

11385

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

5.3

216.0

749

1034

D64.9

ICD-10 Finland

Anaemia, unspecified

2.7

214.7

1738

4853

A01

ICPC

Pain general/multiple sites

3.3

212.0

1231

2753

KMAK

NOMESCO Finland

1.6

208.4

8703

45512

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

3.4

208.2

1137

2425

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.9

207.7

1487

3846

-1

NOMESCO Finland

1.7

205.7

5657

26305

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

4.3

202.0

852

1448

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.0

201.9

1324

3228

N03AX09

ATC

lamotrigine; oral

4.3

200.5

851

1455

M79.1

ICD-10 Finland

Myalgia

2.4

200.3

1909

5829

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.9

200.3

3541

14204

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.7

197.8

5190

23737

C07AA05

ATC

propranolol; systemic

2.1

197.5

2810

10349

XF400

NOMESCO Finland

ECG with 12 standard connections

2.1

197.4

2765

10118

S06.0

ICD-10 Finland

Concussion

2.5

197.1

1855

5623

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.7

196.0

1497

4026

DFF00

NOMESCO Finland

Pure tone audiometry

3.7

195.3

965

1894

R05

ICD-10 Finland

Cough

2.1

194.3

2740

10046

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.4

193.4

1931

6036

Z01.2

ICD-10 Finland

Dental examination

1.6

191.8

6520

32056

D01

ICPC

Abdominal pain/cramps general

2.5

190.3

1695

4984

A28

ICPC

Limited function/disability NOS

2.3

189.0

2075

6796

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

3.9

188.9

875

1622

N06AB06

ATC

sertraline; oral

2.5

188.4

1696

5013

C03CA01

ATC

furosemide; systemic

1.8

188.0

4136

17847

N02AA05

ATC

oxycodone; systemic

2.2

187.8

2200

7426

M01AE01

ATC

ibuprofen; systemic, rectal

1.7

187.1

16349

101979

R06AE07

ATC

cetirizine; oral

1.6

187.0

6600

32723

A98

ICPC

Health maint/preventive medicine

2.0

185.9

18107

116983

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

3.9

184.9

875

1653

EBA00

NOMESCO Finland

Extraction of tooth

1.7

184.6

5719

27338

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.5

184.2

1724

5202

F51.0

ICD-10 Finland

Nonorganic insomnia

2.3

184.1

2017

6594

L01

ICPC

Neck symptom/complaint

2.4

183.9

1872

5902

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.7

183.5

1462

4028

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

3.1

183.1

1136

2659

N05BA01

ATC

diazepam; systemic, rectal

2.3

181.8

2038

6732

R11

ICD-10 Finland

Nausea and vomiting

2.9

180.7

1252

3160

R01AD09

ATC

mometasone; nasal

1.6

179.6

6748

33911

UKC02

NOMESCO Finland

Cystoscopy

2.0

178.5

2659

9941

WX290

NOMESCO Finland

Other blockade of nerve

1.6

178.1

7780

40593

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.5

178.0

9553

52376

-69

ICPC

Other reason for encounter NEC

4.1

176.8

770

1348

M03BC01

ATC

orphenadrine (citrate); systemic

1.8

176.7

3631

15272

N05CF02

ATC

zolpidem; oral

2.1

176.7

2501

9155

P01

ICPC

Feeling anxious/nervous/tense

2.4

172.5

1724

5376

M01AE02

ATC

naproxen; oral, rectal

1.5

172.5

9176

50056

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.0

172.1

2770

10661

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

56.3

171.2

229

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

4.0

170.8

768

1384

R52.9

ICD-10 Finland

Pain, unspecified

2.8

170.7

1278

3384

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

2.1

170.7

2323

8357

N30.0

ICD-10 Finland

Acute cystitis

2.4

170.5

1663

5119

R07.3

ICD-10 Finland

Other chest pain

2.6

170.2

1419

4008

L12

ICPC

Hand/finger symptom/complaint

2.1

169.6

2160

7549

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.7

169.5

1300

3495

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.7

169.1

1341

3677

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.0

168.3

2539

9521

R13

ICD-10 Finland

Dysphagia

3.2

167.4

1013

2325

SPAT1216

SPAT

Assessment of functional ability

2.2

167.4

1949

6541

XCK10

NOMESCO Finland

Photography of fundus of eye

2.7

166.8

1273

3412

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.6

165.6

1432

4128

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.1

165.6

2320

8439

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.9

165.5

1137

2848

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.8

164.3

1205

3148

J01EA01

ATC

trimethoprim; systemic

1.9

164.2

2914

11613

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.6

164.1

1385

3937

D11

ICPC

Diarrhoea

2.3

163.8

1780

5778

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.8

163.8

3799

16566

N01

ICPC

Headache

2.3

163.5

1728

5534

R05

ICPC

Cough

1.9

163.3

3078

12527

J01MA12

ATC

levofloxacin; systemic

1.9

161.9

2882

11490

M01AH05

ATC

etoricoxib; oral

1.5

161.1

9164

50450

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

3.5

160.9

852

1766

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.9

160.8

745

1379

N06AA09

ATC

amitriptyline; systemic

2.7

160.7

1240

3342

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.3

159.8

1710

5504

SPAT1301

SPAT

No procedures

1.7

159.8

4696

21942

ICD-10 Finland

5.9

159.4

500

609

G04CA02

ATC

tamsulosin; oral

1.7

158.9

4569

21209

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.3

158.8

1653

5250

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.9

158.3

1108

2808

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.6

158.2

1305

3659

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.8

157.8

3541

15256

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

2.8

157.5

1141

2957

Z50.1

ICD-10 Finland

Other physical therapy

3.5

157.5

846

1774

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

8.6

155.9

380

318

J01FA06

ATC

roxithromycin; oral

1.6

155.4

5976

29927

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.1

155.3

2148

7759

R21

ICPC

Throat symptom/complaint

1.8

153.9

3112

12947

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

4.3

153.8

644

1084

A02BA02

ATC

ranitidine; systemic

1.9

153.6

2773

11094

J01DA01

ATC

[U] cefalexin; systemic

1.5

152.9

10336

58820

M48.0

ICD-10 Finland

Spinal stenosis

2.3

151.5

1593

5081

N05AH03

ATC

olanzapine; systemic

2.9

150.9

1066

2717

L29

ICPC

Musculoskeletal sympt/complt other

2.8

150.3

1084

2798

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.8

150.0

3346

14361

JN4BD

NOMESCO Finland

Extensive body CT

2.2

149.6

1762

5927

R02

ICPC

Shortness of breath/dyspnoea

2.3

149.3

1638

5331

XCK00

NOMESCO Finland

Perimetry

3.4

149.3

835

1806

K59.09

ICD-10 Finland

Constipation, unspecified

3.1

149.0

911

2104

L08

ICPC

Shoulder symptom/complaint

1.9

149.0

2548

9986

N03AG01

ATC

valproic acid; systemic, rectal

3.0

149.0

996

2448

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.1

148.4

1989

7080

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.8

148.2

1054

2697

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.3

147.5

1554

4956

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.6

147.4

4880

23456

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.5

147.1

6277

32131

J01FA10

ATC

azithromycin; systemic

1.5

146.3

9282

51899

P03

ICPC

Feeling depressed

2.4

146.3

1402

4263

N17

ICPC

Vertigo/dizziness

2.4

146.3

1433

4407

R60.0

ICD-10 Finland

Localized oedema

2.3

145.8

1517

4809

SPAT1254

SPAT

Administration of medicine

2.0

145.8

2264

8549

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.2

145.8

1677

5577

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.5

145.7

6441

33227

W19

ICD-10 Finland

Unspecified fall

2.3

145.2

1608

5254

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

144.8

8312

45448

H02AB04

ATC

methylprednisolone; systemic

2.1

144.7

1991

7162

L15

ICPC

Knee symptom/complaint

1.9

144.3

2657

10681

A03FA01

ATC

metoclopramide; systemic, rectal

1.9

143.7

2654

10680

A06AD11

ATC

lactulose; oral

2.0

143.5

2137

7936

N06AB03

ATC

fluoxetine; oral

2.2

143.1

1679

5634

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.3

142.9

825

1826

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.1

142.5

870

2006

UJH02

NOMESCO Finland

Anoscopy

3.6

141.5

717

1432

M53.1

ICD-10 Finland

Cervicobrachial syndrome

2.3

141.5

1526

4920

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.5

139.8

1298

3878

XF404

NOMESCO Finland

Ambulatory ECG

2.5

139.6

1295

3867

W00

ICD-10 Finland

Fall on same level involving ice and snow

2.2

139.5

1660

5602

J01CA08

ATC

pivmecillinam; oral

1.7

139.1

3692

16655

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.7

138.7

1079

2916

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.8

137.8

1029

2712

A46

ICD-10 Finland

Erysipelas

1.9

136.7

2235

8595

Z04.6

ICD-10 Finland

General psychiatric examination, requested by authority

1107.4

136.6

153

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

49.0

136.1

186

M01AB05

ATC

diclofenac; systemic, rectal

1.5

135.8

10808

62913

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

134.7

5893

30187

J01CE02

ATC

phenoxymethylpenicillin; oral

1.5

134.6

12181

72705

E66.8

ICD-10 Finland

Other obesity

3.3

134.5

772

1700

K92.1

ICD-10 Finland

Melaena

2.9

134.1

926

2322

S97

ICPC

Chronic ulcer skin

3.0

133.2

879

2137

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.9

133.0

2479

9985

R03DC03

ATC

montelukast; oral

2.0

132.1

2100

7984

A03

ICPC

Fever

1.8

130.9

2570

10534

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

4.4

130.2

534

880

K59.1

ICD-10 Finland

Functional diarrhoea

3.3

130.0

744

1635

D06

ICPC

Abdominal pain localized other

2.5

129.6

1117

3201

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

3.3

129.6

752

1669

Z00.8

ICD-10 Finland

Other general examinations

3.0

127.8

827

1984

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

3.6

127.8

641

1269

XF402

NOMESCO Finland

ECG with work load test

2.2

127.5

1436

4717

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

2.3

127.2

1392

4510

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.4

126.9

1235

3776

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.6

126.0

1058

2986

D07AC01

ATC

betamethasone; topical

1.5

125.7

4987

24885

R35

ICD-10 Finland

Polyuria

2.6

125.4

1031

2875

XG410

NOMESCO Finland

Flow-volume spirometry

3.9

125.1

574

1052

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.9

125.0

838

2060

R55

ICD-10 Finland

Syncope and collapse

2.1

124.4

1604

5595

R74

ICPC

Upper respiratory infection acute

1.6

123.7

4228

20326

R03BA02

ATC

budesonide; inhalant

1.8

123.7

2460

10108

L04AX01

ATC

azathioprine; systemic

3.1

123.5

758

1751

DFF15

NOMESCO Finland

Speech audiometry

5.9

123.3

385

466

A07EA06

ATC

budesonide; oral, local oral

3.7

123.3

604

1172

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.2

123.3

735

1663

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.0

122.9

1824

6741

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.7

121.7

3212

14398

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

121.7

5516

28336

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

4.9

121.6

447

657

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.5

121.5

1114

3300

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.5

121.4

1056

3038

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.7

120.8

3033

13396

M54.2

ICD-10 Finland

Cervicalgia

2.6

120.7

1011

2848

H03AA01

ATC

levothyroxine sodium; systemic

1.8

120.7

2343

9545

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

24.9

119.8

189

M01AC06

ATC

meloxicam; systemic, rectal

1.5

118.9

4833

24193

M54.6

ICD-10 Finland

Pain in thoracic spine

2.6

118.7

974

2711

AN1

Coronary angiography

2.0

118.2

1748

6445

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

8.9

117.7

280

225

Y96.9

ICD-10 Finland

Unspecified type of accident

6.0

117.6

364

436

J01MA14

ATC

moxifloxacin; systemic

2.2

117.4

1313

4293

B01AC04

ATC

clopidogrel; oral

1.8

116.8

2281

9304

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.9

116.8

2105

8352

L02

ICPC

Back symptom/complaint

2.3

116.6

1284

4166

M19.0

ICD-10 Finland

Primary arthrosis of other joints

2.3

116.6

1195

3746

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

116.3

4571

22679

G43.9

ICD-10 Finland

Migraine, unspecified

3.1

116.0

732

1725

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.8

116.0

2482

10427

M03BC51

ATC

orphenadrine, combinations; systemic

1.6

116.0

3977

19088

L16

ICPC

Ankle symptom/complaint

2.2

115.9

1388

4682

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.8

115.7

860

2257

N03AE01

ATC

clonazepam; systemic

2.8

115.6

826

2114

U02

ICPC

Urinary frequency/urgency

2.2

115.5

1350

4505

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

2.2

115.3

1349

4502

H04.10

ICD-10 Finland

Dry eye syndrome

2.4

115.1

1097

3314

TND32

NOMESCO Finland

Custom moulded splint, wrist or hand

8.1

115.0

289

255

ND1AA

NOMESCO Finland

Wrist X-ray examination

2.9

115.0

795

1991

Z00.6

ICD-10 Finland

Examination for normal comparison and control in clinical research programme

14.7

114.8

215

104

N07BB01

ATC

disulfiram; oral

2.6

114.3

919

2527

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

4.4

114.1

464

758

J45.1

ICD-10 Finland

Nonallergic asthma

2.6

113.8

966

2741

SFA00

NOMESCO Finland

Small filling

1.9

113.7

1903

7350

A10AE04

ATC

insulin glargine; parenteral

2.1

113.6

1407

4814

R20.2

ICD-10 Finland

Paraesthesia of skin

2.6

113.5

911

2502

C10AA01

ATC

simvastatin; oral

1.5

113.4

5911

31184

P29

ICPC

Psychological sympt/compl other

2.7

113.4

900

2455

R96

ICPC

Asthma

2.4

113.0

1065

3197

127

Kela drug reimbursment

Transplant complication

6.8

112.5

317

334

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.7

112.3

2731

11923

N05BA12

ATC

alprazolam; oral

2.2

112.2

1353

4575

E000001

ATC

1.7

112.1

3048

13744

D19

ICPC

Teeth/gum symptom/complaint

1.6

112.0

3841

18410

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

2.1

111.9

1414

4882

H01

ICPC

Ear pain/earache

2.1

111.7

1463

5127

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.7

111.6

2550

10923

A11

ICPC

Chest pain NOS

2.5

111.2

1006

2954

R06AX27

ATC

desloratadine; oral

1.6

111.1

3785

18105

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

4.4

111.1

448

726

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.2

111.0

1321

4440

M70.6

ICD-10 Finland

Trochanteric bursitis

2.4

111.0

1030

3067

D02

ICPC

Abdominal pain epigastric

2.9

110.7

763

1908

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.9

110.6

738

1806

L13

ICPC

Hip symptom/complaint

2.0

110.6

1631

6001

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.5

110.2

1009

2982

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.9

110.1

2025

8079

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.9

109.9

1744

6598

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.0

109.8

1579

5750

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

2.5

109.7

957

2754

R12

ICD-10 Finland

Heartburn

2.5

109.4

973

2831

N06AX12

ATC

bupropion; oral

2.5

109.3

937

2672

S22.3

ICD-10 Finland

Fracture of rib

2.3

109.1

1130

3558

M01AX17

ATC

nimesulide; oral

1.6

108.9

3089

14076

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.3

108.7

1116

3497

A02BC04

ATC

rabeprazole; oral

2.3

108.6

1118

3508

R29

ICPC

Respiratory symptom/complaint other

2.6

108.5

912

2572

B01AA03

ATC

warfarin; systemic

1.7

108.3

2980

13466

P20

ICPC

Memory disturbance

2.1

108.1

1395

4855

SPAT1229

SPAT

Assessment of need for aid

2.5

108.0

950

2748

S93.4

ICD-10 Finland

Sprain and strain of ankle

2.0

107.9

1644

6121

G47.3

ICD-10 Finland

Sleep apnoea

1.6

107.5

3254

15087

XKD00

NOMESCO Finland

Uroflowmetry

1.7

107.4

2821

12578

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.6

107.3

3205

14806

H02AB07

ATC

prednisone; oral

1.9

106.3

1903

7516

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

106.2

4353

21727

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.7

105.8

804

2135

S21

ICPC

Skin texture symptom/complaint

1.9

105.6

1711

6519

ZXA10

NOMESCO Finland

Bilateral

1.7

105.6

2410

10307

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

3.3

105.2

608

1345

H53.1

ICD-10 Finland

Subjective visual disturbances

2.7

105.0

783

2057

NA1AD

NOMESCO Finland

Cervical spine CT examination

3.0

105.0

689

1667

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.1

105.0

1322

4553

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

5.3

104.9

356

478

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.8

104.8

498

941

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

4.0

104.7

469

841

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

2.4

104.5

975

2910

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.8

104.1

2175

9045

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.6

104.0

3648

17540

K29.7

ICD-10 Finland

Gastritis, unspecified

3.4

103.4

554

1156

L04AA06

ATC

mycophenolic acid; systemic

5.8

103.0

326

402

A99

ICPC

Disease/condition unspecnature/site

2.3

102.7

1122

3622

F43.1

ICD-10 Finland

Post-traumatic stress disorder

4.6

102.5

394

608

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.9

102.0

681

1667

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

3.0

101.9

672

1631

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

6.4

101.8

299

334

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.5

101.6

5379

28323

R4190

NOMESCO Finland

Nutritional therapy

3.3

101.3

585

1293

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

5.4

100.7

339

451

103

Kela drug reimbursment

Diabetes, insulin-treated

1.5

100.6

3808

18623

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

3.1

100.6

617

1425

JN3AD

NOMESCO Finland

Abdominal CT examination

2.2

100.5

1147

3777

T90

ICPC

Diabetes non-insulin dependent

1.6

100.4

3089

14349

T78.4

ICD-10 Finland

Allergy, unspecified

3.1

100.3

610

1400

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.6

100.2

3204

15035

J31.0

ICD-10 Finland

Chronic rhinitis

2.3

100.2

1022

3189

SPAT1310

SPAT

Counselling related to known health issue

1.5

100.1

4425

22418

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

3.3

99.9

562

1218

WX320

NOMESCO Finland

Spinalanesthesy

1.6

99.8

3065

14234

N06AX26

ATC

vortioxetine; oral

2.6

99.6

829

2323

SPAT1285

SPAT

Provision of consultation response

2.6

99.3

798

2191

Z01.7

ICD-10 Finland

Laboratory examination

2.0

99.3

1407

5085

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.8

99.1

2057

8527

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

3.2

99.0

585

1315

R52.2

ICD-10 Finland

Other chronic pain

4.2

98.6

422

725

R07.0

ICD-10 Finland

Pain in throat

2.5

98.6

895

2630

R00.2

ICD-10 Finland

Palpitations

2.5

98.5

843

2400

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

98.5

3888

19190

J05AB01

ATC

aciclovir; systemic

1.7

98.3

2608

11633

R03AC03

ATC

terbutaline; inhalant

1.8

98.2

1894

7662

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.2

98.2

1094

3563

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.5

98.1

3949

19576

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.4

98.0

7887

44861

WX892

NOMESCO Finland

Monitored bed care

2.2

97.9

1181

3987

P76

ICPC

Depressive disorder

2.5

97.8

856

2467

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.6

97.5

3320

15813

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.8

97.5

1843

7406

N40

ICD-10 Finland

Hyperplasia of prostate

1.5

97.4

3920

19424

P15

ICPC

Chronic alcohol abuse

3.2

96.9

583

1327

C08CA01

ATC

amlodipine; oral

1.5

96.6

4820

25020

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.1

96.2

1265

4432

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.4

96.0

527

1121

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

4.5

96.0

381

608

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.3

96.0

967

3000

NF1AA

NOMESCO Finland

Hip X-ray examination

2.2

95.9

1068

3475

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.6

95.4

778

2154

H29

ICPC

Ear symptom/complaint other

2.1

94.9

1241

4338

I50.9

ICD-10 Finland

Heart failure, unspecified

1.8

94.7

1892

7740

XA420

NOMESCO Finland

Extensive sleep examination

8.4

94.6

232

197

SPAT1240

SPAT

Therapeutic discussion

1.9

94.3

1491

5617

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.8

94.2

1837

7453

S80.0

ICD-10 Finland

Contusion of knee

2.4

94.0

914

2782

R01AD12

ATC

fluticasone furoate; nasal

1.5

93.8

4105

20698

T74.1

ICD-10 Finland

Physical abuse

4.2

93.7

393

662

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.4

93.6

888

2669

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.0

93.6

1304

4676

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

4.7

93.5

355

541

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.1

93.2

1247

4399

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

2.7

93.1

697

1833

SPAT1153

SPAT

Removal of sutures

1.5

93.1

4186

21224

B18.2

ICD-10 Finland

Chronic viral hepatitis C

5.6

93.0

300

379

F41.09

ICD-10 Finland

UNS Panic Syndrome

3.7

93.0

449

860

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.1

93.0

1240

4369

J01FA09

ATC

clarithromycin; systemic

1.5

92.9

4463

22948

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.3

92.7

937

2910

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.9

92.6

1619

6327

K29

ICPC

Cardiovascular sympt/complt other

3.1

92.4

569

1316

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.6

92.4

2842

13175

S52.5

ICD-10 Finland

Fracture of lower end of radius

2.2

92.3

1109

3735

K59.0

ICD-10 Finland

Constipation

2.6

92.0

756

2101

A05

ICPC

Feeling ill

2.3

91.7

975

3103

Z04.5

ICD-10 Finland

Examination and observation following other inflicted injury

90.5

91.6

115

R03BA05

ATC

fluticasone; inhalant

1.7

90.8

2407

10716

DFF30

NOMESCO Finland

Loudness discomfort Level (LDL)

6.7

90.7

258

276

C03DA01

ATC

spironolactone; oral

1.9

90.6

1469

5583

SPAT1312

SPAT

General health counselling

1.5

90.4

4738

24774

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.2

90.4

537

1211

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1933

4333

2.80

322.35

1.6

titre

264.3

284.3

0.09

184

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

31504

169533

1.69

321.69

4.1

3.4

mmol/l

1.3

5.67

29575

156792

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

6340

23206

1.79

320.09

2.5

1.9

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1917

4294

2.80

320.07

2.3

2.1

g/l

10.1

10.4

2.54

1698

3660

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1835

4012

2.87

319.84

2.3

2.4

g/l

0.5

0.9

3.82

1656

3441

(3020961) Endomysium IgA Ab [Titer] in Serum

2809

7634

2.33

318.43

1.2

1.1

titre

123.5

251.4

2.10

231

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

33159

181214

1.77

316.08

5.1

4.2

mmol/l

2.7

2.8

98.33

31294

167963

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

2032

4730

2.70

316.06

2.1

1.7

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

3037

8614

2.24

311.95

1.3

1.2

au/ml

50.0

48.9

0.07

100

422

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2376

6042

2.48

310.41

1.1

u/ml

7.3

8.1

0.05

(3018405) Lactate [Moles/volume] in Arterial blood

1978

4602

2.70

307.78

5.2

4.0

mmol/l

1.3

1.4

7.34

1959

4528

(3037467) Urinalysis macro (dipstick) panel - Urine

25883

114594

2.12

307.65

5.1

3.5

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

14538

54771

1.98

307.65

4.0

3.0

ng/l

37.9

60.4

4.09

9619

34208

(3019309) Folate [Moles/volume] in Red Blood Cells

7512

23733

2.15

307.65

1.8

nmol/l

1205.3

1205.4

0.00

6009

17810

(3020630) Protein [Mass/volume] in Serum or Plasma

3840

10421

2.38

307.65

2.6

2.3

g/l

66.3

66.6

1.46

3514

9575

(3030467) Casts [#/volume] in Urine by Automated count

13238

43956

2.26

307.65

3.8

2.7

e6/l

0.3

0.5

7.66

10602

31114

(3012095) Magnesium [Moles/volume] in Serum or Plasma

7357

23084

2.16

307.65

4.2

3.1

mmol/l

0.8

11.77

6964

21547

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

36091

194776

2.81

307.65

13.3

8.1

u/l

26.4

27.0

4.41

35324

187573

(3000494) Fungus identified in Specimen by Culture

5282

16785

2.06

307.65

1.6

1.3

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2012

4495

2.82

307.65

2.3

2.1

g/l

3.8

4.0

5.00

1615

3339

(3021601) Nitrite [Presence] in Urine by Test strip

19449

84143

1.81

307.65

5.8

4.1

estimate

0.0

0.46

1745

17088

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

2316

4027

3.65

307.65

1.3

1.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

6660

16555

2.75

307.65

3.5

2.4

umol/l

7.0

9.1

10.81

5939

14242

(3000850) Epithelial cells [#/volume] in Urine

9636

32334

2.08

307.65

2.9

2.3

e6/l

5.4

6.0

3.14

8638

27891

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

7947

26946

2.00

307.65

2.9

3.2

mmol/l

2.4

9.17

6988

23405

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

32547

170092

2.01

307.65

4.8

3.8

mmol/l

5.9

5.8

36.13

30558

155778

(3007853) Bacteria identified in Skin by Aerobe culture

6171

16599

2.50

307.65

2.0

1.6

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

19305

65151

2.59

307.65

7.6

5.3

mmol/l

1.2

1.20

18111

59043

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

35444

179692

3.30

307.65

19.7

10.6

mg/l

23.0

24.7

17.05

29251

136621

(40758558) Short blood count panel - Blood

14505

37902

3.12

307.65

8.3

6.1

—

(1761868) Lipid panel - Serum or Plasma

8558

75391

0.60

307.65

2.4

2.7

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

8660

26827

2.24

307.65

4.1

3.2

ng/l

351.9

589.0

5.94

6507

20172

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2996

6820

2.81

307.65

5.3

3.6

mmol/l

24.1

24.2

0.25

2744

6136

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

2154

4948

2.74

307.65

1.5

1.4

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

4672

12919

2.36

307.65

4.9

3.4

kpa

5.9

5.8

2.16

4542

12580

(3042936) Bacteria identified in Isolate by Culture

6619

20302

2.18

307.65

2.4

1.8

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2635

6639

2.52

307.65

2.4

2.3

—

(3033658) Prothrombin time (PT) actual/Normal

12352

41507

2.19

307.65

5.5

3.4

90.5

90.4

0.33

12053

40533

(3028026) IgM [Mass/volume] in Serum or Plasma

3167

7929

2.55

307.65

1.9

g/l

1.3

0.06

2930

7254

(3014576) Chloride [Moles/volume] in Serum or Plasma

6568

18068

2.46

307.65

8.5

6.9

mmol/l

104.4

104.5

0.38

6525

17588

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

8506

24184

2.46

307.65

3.3

2.6

e6/l

2.9

2.8

0.41

5061

11234

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

4115

9158

2.94

307.65

1.8

1.5

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

4455

13096

2.21

307.65

9.0

7.9

g/l

119.6

122.7

17.11

4397

12594

(3000330) Specific gravity of Urine by Test strip

2835

6604

2.74

307.65

3.2

3.0

—

(3005719) IgG [Mass/volume] in Serum or Plasma

3930

10083

2.52

307.65

2.8

2.5

g/l

10.5

10.8

3.93

3698

9134

(40768797) Stomach Pathology biopsy report

8377

17488

3.44

307.65

1.3

1.2

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

29411

123598

2.84

307.65

9.4

6.4

u/l

77.9

77.8

0.17

28158

115583

(40768804) Tissue Pathology biopsy report

16465

65236

1.93

307.65

2.2

1.9

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

25225

126704

1.60

307.65

3.6

3.0

—

(3026493) Urate [Moles/volume] in Serum or Plasma

10475

41557

1.73

307.65

2.9

2.3

umol/l

2455.9

5262.9

13.71

9241

36366

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3653

8767

2.69

307.65

4.7

3.5

ng/l

94.0

87.9

2.60

3339

7532

(3020779) Urea [Moles/volume] in Serum or Plasma

4323

11751

2.39

307.65

9.8

5.9

mmol/l

9.4

9.5

0.60

4137

11177

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

13896

45087

2.36

307.65

3.0

2.3

u/l

57.0

59.7

4.48

13035

41408

(42529406) Shigella sp [Presence] in Stool by Culture

2349

4059

3.68

307.65

1.3

1.1

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

2009

4233

2.99

307.65

2.6

2.2

ug/l

383.7

616.2

2.11

1901

3980

(3022217) INR in Platelet poor plasma by Coagulation assay

6980

14197

3.42

307.65

23.7

24.4

inr

1.4

1.3

1.20

355

1754

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

18406

77228

1.85

307.65

4.3

3.7

—

(3027945) Reticulocytes/100 erythrocytes in Blood

5395

15095

2.36

307.65

2.8

2.4

1.8

1.7

14.18

4888

13445

(3019150) Specific gravity of Urine by Refractometry

10505

34149

2.19

307.65

5.3

3.2

kg/l

1.0

0.74

901

5041

(36660697) Celiac disease serology panel - Serum

4316

11828

2.37

307.65

1.2

1.1

—

(3002582) Erythrocytes [#/volume] in Urine

13375

48099

2.05

307.65

3.9

2.8

e6/l

55.1

108.9

6.09

10676

34790

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

5750

15158

2.53

307.65

1.9

1.6

—

(3035350) Ketones [Presence] in Urine by Test strip

19342

83713

1.81

307.65

4.5

3.0

estimate

0.0

2.09

1657

16736

(3026008) Bacteria identified in Urine by Culture

11771

43841

1.91

307.65

3.4

2.6

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

6178

13736

3.06

307.65

3.1

2.3

u/l

52.4

45.9

0.22

5332

11844

(3018677) aPTT in Platelet poor plasma by Coagulation assay

7257

21946

2.24

307.65

2.7

1.9

30.0

29.9

0.41

7103

21334

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

3389

7118

3.08

307.65

1.8

1.5

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

2347

4051

3.68

307.65

1.3

1.1

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

28561

130404

2.26

307.65

4.6

3.5

pmol/l

14.7

0.31

26713

118094

(3000991) Gas panel - Venous blood

4659

12459

2.45

307.65

9.8

7.9

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

7290

21558

2.30

307.65

2.0

1.6

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

5389

15463

2.30

307.65

4.8

3.9

u/l

238.8

245.3

1.61

5128

14715

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

5312

15443

2.26

307.65

8.2

7.3

kpa

5.1

0.06

5155

14705

(3048689) Calprotectin [Mass/mass] in Stool

7480

17984

2.89

307.65

2.7

2.5

ug/g

123.2

138.4

2.85

6053

14324

(3022145) Colonoscopy Study observation

5782

16261

2.36

307.65

1.4

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

6952

18698

2.54

307.65

3.2

2.2

21.9

23.5

14.10

6369

16003

(3002032) Base excess in Venous blood by calculation

4672

12862

2.37

307.65

5.0

3.4

mmol/l

1.8

0.15

3897

10649

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

4657

13065

2.33

307.65

3.0

2.0

g/l

0.2

0.48

4360

12150

(3006315) Basophils [#/volume] in Blood

21926

77970

2.63

307.65

7.6

5.1

e9/l

0.0

1.19

19498

65579

(3021879) Hepatitis B virus core Ab [Presence] in Serum

4324

13068

2.14

307.65

1.6

1.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

6473

19782

2.19

307.65

1.9

1.5

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2014

4504

2.81

307.65

2.3

2.1

g/l

7.2

7.4

2.50

1663

3506

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

20350

70893

2.57

307.65

8.2

5.5

mmol/l

1.2

9.04

18589

57136

(3002030) Lymphocytes/100 leukocytes in Blood

19621

77444

2.09

307.65

7.8

5.2

28.3

0.05

18517

72177

(3013115) Eosinophils [#/volume] in Blood

22439

80645

2.64

307.65

8.0

5.2

e9/l

0.2

0.18

20207

69471

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

11094

36247

2.21

307.65

3.4

2.7

ng/l

1420.2

1402.3

0.12

9632

30707

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

3568

9015

2.55

307.65

10.0

9.1

1.4

1.3

5.49

3547

8958

(3022948) Iron [Moles/volume] in Serum or Plasma

8009

21801

2.55

307.65

3.0

2.2

umol/l

12.8

13.6

11.64

7556

20162

(3020891) Body temperature

2352

5608

2.65

307.65

5.9

4.5

—

(3019198) Lymphocytes [#/volume] in Blood

22297

81070

2.58

307.65

7.7

5.1

e9/l

1.9

0.36

20145

70082

(36304419) Bacteria [Presence] in Urine

13080

43268

2.26

307.65

3.7

2.7

—

(3005322) IgE [Units/volume] in Serum or Plasma

3239

8523

2.43

307.65

1.4

1.2

u/ml

221.7

256.2

0.77

3019

7875

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1625

3128

3.25

307.65

1.4

1.2

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2777

7400

2.38

307.65

10.4

9.8

mmol/l

24.3

24.4

1.02

2617

6958

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

3569

9010

2.55

307.65

10.0

9.2

0.7

3.04

3551

8961

(3023368) Bacteria identified in Blood by Culture

11401

39482

2.07

307.65

5.0

4.0

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

35356

180738

3.13

307.65

21.6

12.2

mmol/l

4.0

4.80

34719

174803

(3045414) Leukocytes [Presence] in Urine

3335

5301

4.09

307.65

2.2

1.6

—

(40761511) CBC panel - Blood by Automated count

35947

191966

2.88

307.65

16.3

10.1

—

(3014051) Protein [Presence] in Urine by Test strip

2254

2324

6.20

307.65

2.5

1.7

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

14541

53007

2.07

307.65

3.9

2.7

u/l

34.4

34.0

0.12

13974

50071

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

3333

9447

2.25

307.65

2.4

2.3

au/ml

23.3

22.8

0.09

171

716

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

11982

35151

2.55

307.65

2.9

2.0

mg/l

3.0

2.9

6.70

10472

29799

(3013650) Neutrophils [#/volume] in Blood by Automated count

24397

92015

2.65

307.65

11.0

8.1

e9/l

4.1

4.2

3.69

21835

78266

(3013707) Erythrocyte sedimentation rate by Westergren method

28319

119872

2.61

307.65

4.9

3.3

mm/h

12.0

11.2

16.15

26794

110599

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

16827

61000

2.20

307.65

2.6

2.0

nmol/l

75.2

75.5

0.78

15441

55245

(3000963) Hemoglobin [Mass/volume] in Blood

37302

209639

3.11

307.65

29.1

15.4

g/l

133.4

137.0

307.65

37001

206369

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

30685

158304

1.85

307.65

6.1

4.6

mmol/mol

39.4

38.8

26.24

29022

146863

(3022096) Basophils/100 leukocytes in Blood

18582

71410

2.12

307.65

7.7

5.3

0.7

14.48

17564

66517

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

7907

30118

1.75

307.65

1.9

1.6

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

5383

10645

3.41

307.65

3.3

2.2

ml/min/173m2

63.6

69.5

14.92

1834

4276

(3010813) Leukocytes [#/volume] in Blood

37303

209587

3.12

307.65

29.0

15.4

e9/l

6.8

6.7

12.63

36645

201956

(3004789) Transferrin [Mass/volume] in Serum or Plasma

7388

20098

2.52

307.65

3.0

2.2

g/l

2.4

2.3

2.08

6987

18437

(3018418) pH of Serum or Plasma

13605

44833

2.30

307.65

5.2

3.6

7.4

1.23

1113

10200

(3019550) Sodium [Moles/volume] in Serum or Plasma

35301

179991

3.13

307.65

21.5

12.1

mmol/l

139.5

139.7

22.43

34735

174458

(3004716) Salmonella sp identified in Stool by Organism specific culture

3228

8803

2.34

307.65

1.4

—

(3006504) Eosinophils/100 leukocytes in Blood

19150

73706

2.14

307.65

7.7

5.2

2.9

2.8

2.77

18141

68546

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2357

5689

2.62

307.65

1.5

u/ml

12.2

13.4

0.18

149

(3024354) Oxygen [Partial pressure] in Venous blood

4030

10659

2.45

307.65

4.1

2.8

kpa

4.7

4.6

1.77

3891

10334

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1736

3575

3.04

307.65

2.3

2.2

g/l

0.0

0.28

1611

3274

(46235355) HIV 1 and 2 tests - Meaningful Use set

9264

36410

1.72

307.65

2.2

1.8

—

(3018010) Neutrophils/100 leukocytes in Blood

19453

75950

2.12

307.65

7.6

5.1

56.9

57.1

1.39

18456

71093

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

32980

166451

2.36

307.65

15.9

10.5

ml/min/173m2

85.1

84.6

2.93

27704

132857

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

17633

57013

2.61

307.65

2.2

1.7

pmol/l

94.7

95.2

0.58

9654

29569

(3009542) Hematocrit [Volume Fraction] of Blood

33091

175235

2.00

307.65

21.3

11.4

39.8

40.3

33.96

26186

134426

(3003458) Phosphate [Moles/volume] in Serum or Plasma

6194

17488

2.37

307.65

7.3

4.8

mmol/l

1.1

1.0

4.49

5836

16283

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

3641

7258

3.26

307.65

1.6

1.4

—

(3037522) Nuclear Ab [Titer] in Serum

6761

19822

2.30

307.65

1.4

1.3

titre

523.0

532.9

0.14

1332

3574

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

5821

15293

2.55

307.65

1.9

1.6

—

(3044889) 12 lead EKG panel

25162

118352

1.83

307.65

4.3

3.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1679

3375

3.12

307.65

2.4

2.2

g/l

0.0

0.13

1557

3082

(3024731) MCV [Entitic volume]

37296

209508

3.12

307.65

28.8

15.3

90.8

90.5

23.84

36982

206173

(3021960) Folate [Moles/volume] in Serum or Plasma

9954

31663

2.23

307.65

1.7

1.5

nmol/l

20.5

20.0

2.52

8900

27277

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

7528

25829

1.96

307.65

1.3

1.2

iu/ml

36.9

37.9

0.05

2192

8282

(3014007) Fractional oxyhemoglobin in Arterial blood

3596

9068

2.55

307.65

10.0

9.2

93.9

93.8

0.17

3586

9036

(3015736) pH of Urine

16156

64721

1.89

307.65

4.5

2.8

5.6

5.8

—

(3018095) Leukocytes [#/volume] in Urine

15459

56923

2.08

307.65

4.5

3.1

e6/l

70.0

100.0

5.41

11545

37686

(3016502) Oxygen saturation in Arterial blood

4845

13732

2.31

307.65

8.7

7.7

95.7

0.00

4734

13186

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

4860

9601

3.37

307.65

2.8

2.0

ug/l

6.6

8.5

5.55

4272

8443

(3011397) Hemoglobin [Presence] in Urine by Test strip

13787

35903

3.07

307.65

4.5

2.9

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1667

3334

3.13

307.65

2.4

2.2

g/l

0.0

0.00

1555

3074

(3013139) Helicobacter pylori Ag [Presence] in Stool

3683

9442

2.51

307.65

1.3

1.2

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

4309

11963

2.34

307.65

2.3

2.2

nmol/l

368.5

381.2

3.40

3935

11156

(3019069) Monocytes/100 leukocytes in Blood

19256

74198

2.15

307.65

8.0

5.4

8.5

8.6

3.48

18289

69437

(3001122) Ferritin [Mass/volume] in Serum or Plasma

18841

72158

2.14

307.65

3.7

2.5

ug/l

112.2

121.1

3.85

17802

67099

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

7090

15288

3.23

307.65

9.8

5.5

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

9967

25839

2.81

307.65

3.1

2.5

e6/l

1.0

1.3

2.06

6468

12828

(4010399)

3399

9658

2.25

307.65

1.5

1.4

—

(3022621) pH of Urine by Test strip

3356

9578

2.24

307.65

2.8

2.6

—

(3021589) Normoblasts [#/volume] in Blood

16896

76494

1.61

307.65

9.7

8.8

e9/l

0.0

0.93

13918

61026

(3027801) Oxygen [Partial pressure] in Arterial blood

5310

15432

2.26

307.65

8.2

7.3

kpa

12.6

12.7

0.75

5153

14689

(3007164) IgA [Mass/volume] in Serum or Plasma

10126

29538

2.47

307.65

1.6

1.4

g/l

2.3

2.4

1.60

5777

18695

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

22124

78157

2.68

307.65

7.0

5.6

umol/l

11.0

11.9

15.83

21130

73755

(3032080) INR in Blood by Coagulation assay

14950

60618

1.81

307.65

8.7

8.1

inr

1.2

0.66

3455

19626

(3009261) Glucose [Presence] in Urine by Test strip

19580

85019

1.81

307.65

4.6

3.0

estimate

0.0

0.14

1705

16575

(3003396) Base excess in Arterial blood by calculation

5387

15599

2.28

307.65

8.2

7.2

mmol/l

1.0

0.9

0.68

4302

12378

(3009508) Creatinine [Moles/volume] in Urine

11409

45944

1.72

307.65

3.7

2.9

mmol/l

7.6

8.1

21.58

9976

38770

(3003327) Ova and parasites identified in Stool by Light microscopy

2268

4808

2.98

307.65

1.8

1.7

—

(3001604) Monocytes [#/volume] in Blood

21885

77692

2.63

307.65

7.6

5.1

e9/l

0.6

33.29

19457

65344

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1881

3241

3.66

307.65

1.4

ug/g

273.3

268.6

0.37

1114

1875

(3024561) Albumin [Mass/volume] in Serum or Plasma

17891

64271

2.28

307.65

5.9

4.3

g/l

35.9

35.7

4.29

16971

59410

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

10380

32534

2.28

307.65

2.2

1.6

mg/l

1.2

1.12

7879

24871

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

24303

120721

1.60

307.65

3.8

2.6

u/l

50.1

45.0

12.10

23092

113535

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

7040

24084

1.95

307.65

1.3

1.2

u/ml

12.6

11.7

0.21

2361

9811

(3012544) pH of Venous blood

4721

13398

2.30

307.65

4.9

3.4

7.4

0.72

(40761535) Cells panel - Urine sediment

5879

9672

4.18

307.65

4.2

2.9

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1775

3669

3.03

307.65

2.3

2.1

g/l

37.9

37.6

0.95

1597

3206

(42870588) Differential panel, method unspecified - Blood

14840

52145

2.18

307.65

7.4

5.3

—

(3044640) Blood type and Crossmatch panel - Blood

13180

50425

1.89

307.65

2.9

2.1

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

12968

41012

2.39

307.65

2.5

1.9

u/l

203.7

228.0

1.05

12336

38280

(3026361) Erythrocytes [#/volume] in Blood

37299

209541

3.12

307.65

29.0

15.3

e12/l

4.4

4.6

302.56

36634

201931

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

32587

159695

2.50

307.65

5.5

4.0

mu/l

1.8

2.2

8.70

30775

146409

(3004588) Protein electrophoresis panel - Serum or Plasma

3097

8445

2.34

307.65

2.6

2.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

11223

34102

2.41

307.65

1.4

1.2

u/ml

2.1

1.8

1.14

2636

9817

(3023520) Reticulocytes [#/volume] in Blood

4019

10525

2.47

307.65

2.6

2.5

e9/l

72.8

68.7

7.73

2986

7466

(3031040) Bacteria [#/volume] in Urine by Automated count

26105

107334

2.46

307.65

5.5

3.6

e6/l

1950.7

1209.5

0.33

105

2125

(3035941) MCH [Entitic mass]

37290

209484

3.11

307.65

28.8

15.3

30.2

1.51

36979

206155

(3007461) Platelets [#/volume] in Blood

37279

209233

3.12

307.65

29.0

15.4

e9/l

254.5

252.0

9.95

36691

202325

(3014111) Lactate [Moles/volume] in Serum or Plasma

5293

12295

2.87

307.65

7.4

7.1

mmol/l

1.3

0.31

5163

11906

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

10607

36724

2.04

307.65

2.8

2.0

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

22497

91622

2.17

307.65

6.1

4.1

mmol/l

6.6

0.30

21252

84090

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1933

4253

2.86

307.65

2.3

2.1

g/l

3.1

0.05

1629

3455

(3043409) Potassium [Moles/volume] in Arterial blood

1864

3956

2.96

307.65

5.3

4.2

mmol/l

3.9

1.06

1831

3609

(3015377) Calcium [Moles/volume] in Serum or Plasma

13232

50311

1.91

307.65

3.4

mmol/l

2.4

1.92

11658

44808

(3003338) MCHC [Mass/volume]

31977

164023

2.05

307.65

26.7

13.1

g/l

331.8

333.2

129.27

31809

162559

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2014

4501

2.81

307.65

2.3

2.1

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

36046

193336

2.88

307.65

21.5

12.3

umol/l

77.1

76.0

5.56

36037

193218

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

5892

20644

1.87

307.65

2.4

1.8

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2617

5631

2.96

307.65

1.8

1.6

g/l

1.5

1.34

2263

4760

(3028707) Methadone [Presence] in Urine by Screen method

1461

2221

4.12

307.65

4.2

2.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2936

8300

2.24

303.62

1.1

1.0

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

32644

178079

1.72

303.40

4.6

3.8

mmol/l

4.6

4.7

131.59

30923

166362

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1812

4097

2.77

297.04

1.8

1.6

g/l

1.2

0.72

1723

3935

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

5938

21779

1.78

295.37

2.1

1.6

1.5

1.4

32.65

5279

19372

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1834

4188

2.74

295.22

5.0

3.3

mmol/l

24.6

24.8

3.15

1727

3891

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1765

3969

2.78

292.14

1.8

1.6

g/l

0.2

3.87

1672

3799

(3024980) IgG subclass 4 [Mass/volume] in Serum

1178

2059

3.56

291.94

1.7

1.5

g/l

0.7

0.9

3.33

1028

1424

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2503

6727

2.35

289.98

3.7

2.6

1.4

1.3

2.52

2493

6691

(3025941) Bacteria identified in Stool by Culture

3083

9072

2.16

288.94

1.4

1.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

32351

176742

1.68

285.38

4.5

3.7

mmol/l

1.4

1.5

4.73

30518

164244

(3007566) Smooth muscle Ab [Titer] in Serum

1729

3899

2.77

284.60

1.4

1.2

titre

104.1

131.3

0.58

123

388

(3002385) Erythrocyte distribution width [Ratio]

29418

157055

1.57

284.41

23.1

13.2

13.8

13.6

61.69

29114

152956

(3034770) Mitochondria Ab [Titer] in Serum

1706

3823

2.79

284.02

1.4

1.2

titre

701.5

1189.1

1.78

102

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1616

3520

2.87

282.96

1.5

iu/ml

10.0

13.3

0.41

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2434

6615

2.32

274.62

3.6

2.6

0.6

0.7

0.66

2357

6302

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

4254

14395

1.89

271.59

3.7

4.3

ug/l

16.5

31.3

2.13

3384

11472

(3012516) Albumin [Mass/volume] in Urine

9800

41843

1.57

269.34

3.5

3.0

mg/l

337.1

325.4

0.10

6564

26456

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

8506

35137

1.60

268.72

1.7

1.5

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

2090

5387

2.44

264.39

1.3

1.2

u/ml

0.7

0.00

200

515

(3019060) Gas panel - Arterial blood

2878

8594

2.12

258.89

5.2

4.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2061

5334

2.42

258.34

1.7

—

(3020682) Albumin/Creatinine [Ratio] in Urine

10161

44268

1.54

252.19

4.0

3.7

mg/mmol

11.8

8.6

6.06

6670

27944

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2137

5699

2.35

250.88

1.4

—

(3036489) Thrombin time

2137

5735

2.34

247.32

2.7

1.9

21.5

21.4

0.41

1904

4983

(3052851) Hemolysis interference index of Serum or Plasma

1807

4541

2.49

240.53

3.6

3.0

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1278

2672

2.97

239.65

1.7

1.4

—

(3011288) Drugs identified in Urine by Screen method

1835

4671

2.46

237.78

5.4

2.3

—

(3026782) Osmolality of Urine

7577

31234

1.59

237.11

3.1

2.4

mosm/kgh2o

543.2

559.9

7.89

6447

26346

(3019225) pH of Specimen

3296

10683

1.96

236.97

4.7

3.4

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

878

1463

3.71

232.20

1.6

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2455

7197

2.15

230.40

4.6

3.0

mmol/l

1.5

1.9

7.76

1785

5217

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

2918

9157

2.01

229.28

3.2

3.5

pmol/l

4.4

4.6

6.39

2588

8291

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1608

3917

2.56

227.75

1.7

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2707

8282

2.06

227.63

8.6

6.5

mmol/l

24.6

24.5

0.72

2605

7630

(3009343) pH of Capillary blood

2492

7394

2.12

226.80

4.6

3.1

7.4

0.88

206

1529

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2142

5988

2.24

225.34

4.1

3.6

53.0

47.9

17.26

2122

5927

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2505

7467

2.11

225.28

4.6

3.1

kpa

5.1

0.50

2355

6985

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

3778

13106

1.83

220.61

2.4

1.7

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1890

5059

2.34

219.42

3.7

3.6

u/ml

667.3

2712.3

0.99

1614

4357

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1492

3565

2.61

219.38

1.2

u/ml

38.7

36.6

0.08

229

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1721

4416

2.43

218.96

3.4

2.2

182.3

187.8

1.66

1641

4190

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

3093

10076

1.94

218.37

2.1

1.6

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1242

2710

2.85

216.11

1.6

1.3

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1234

2688

2.85

215.36

7.5

3.8

iu/ml

1305.2

3674.6

0.47

192

284

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1991

5522

2.26

213.09

2.0

1.9

u/l

39.5

39.1

0.39

1789

4902

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1720

4470

2.40

212.87

3.6

2.9

u/ml

0.3

0.4

2.52

998

2419

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

6769

27937

1.57

207.10

1.5

1.4

—

(3029937) Albumin [Presence] in Urine by Test strip

10152

45765

1.47

205.51

5.5

3.3

estimate

0.0

0.34

1679

16230

(3023511) Choriogonadotropin [Units/volume] in Urine

1384

3321

2.59

201.61

1.5

1.2

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1686

4452

2.36

201.38

1.4

1.6

iu/ml

1.4

2.2

0.18

426

922

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

962

1895

3.14

198.65

1.4

1.3

u/l

22.2

25.8

2.39

772

1615

(3022313) Gas panel - Capillary blood

1792

4915

2.28

196.47

5.1

3.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1707

4584

2.32

196.34

3.5

2.3

g/l

3.5

3.7

6.01

1637

4380

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1794

4951

2.26

193.85

3.1

2.0

92.2

91.7

0.39

1725

4572

(3004119) Hemoglobin [Mass/volume] in Venous blood

2683

8683

1.94

192.10

3.9

2.9

g/l

126.0

131.2

22.66

2650

8483

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3107

10599

1.85

189.85

2.8

2.5

ng/l

232.7

204.2

1.94

2783

9588

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1232

2881

2.65

188.52

1.3

1.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1401

3513

2.48

186.61

2.1

2.0

mg/l

12.7

10.3

15.32

1314

3326

(1001926) Buprenorphine [Presence] in Urine by Screen method

1990

5824

2.14

186.52

3.6

1.8

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1919

5543

2.16

185.80

1.4

1.3

miu/ml

226.1

228.4

0.09

799

2679

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

693

1144

3.73

185.49

1.3

1.2

titre

175.8

149.7

0.12

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

694

1148

3.72

185.24

1.3

1.2

titre

190.8

206.9

0.17

127

178

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1109

2474

2.78

185.22

1.2

u/ml

4.4

14.8

0.88

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1176

2717

2.68

184.08

1.3

1.2

u/ml

276.8

253.8

1.67

820

1751

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1337

3299

2.52

184.02

1.2

u/ml

11.3

10.2

0.15

154

449

(40761536) Microorganisms panel - Urine sediment

1478

18770

0.46

183.80

4.9

3.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1063

2333

2.82

182.81

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

651

1039

3.86

182.26

1.7

1.5

—

(3023183) Ammonium ion [Moles/volume] in Plasma

1154

2663

2.68

181.02

3.4

2.4

umol/l

34.1

35.1

0.58

1015

2180

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

946

1957

2.99

180.21

3.7

2.1

u/ml

655.8

3881.5

2.09

100

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1206

2858

2.62

179.79

1.2

u/ml

40.4

47.0

0.51

107

283

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1119

2553

2.71

179.30

1.2

u/ml

5.4

6.9

0.14

193

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1474

3867

2.37

178.25

1.3

1.2

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1217

2913

2.59

177.92

1.6

1.3

u/ml

16.4

22.9

0.68

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1304

3256

2.48

175.08

1.2

u/ml

5.5

10.4

0.98

101

300

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

604

945

3.93

173.53

1.7

1.6

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1210

2946

2.54

170.96

1.6

1.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1153

2751

2.60

169.55

1.6

1.3

u/ml

104.7

0.00

195

668

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

2216

7054

1.96

165.57

2.5

2.1

u/l

5531.8

6592.6

0.63

737

2889

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

500

697

4.40

165.51

2.5

2.2

e6/l

774.1

674.3

1.20

136

257

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

3937

14949

1.67

165.33

4.2

3.9

31.8

31.7

0.23

2722

10257

(3017732) Neutrophils [#/volume] in Blood

2838

9846

1.81

163.33

2.9

2.5

e9/l

4.2

0.13

2143

8031

(3048929) Epstein Barr virus Ab [Presence] in Serum

1800

5337

2.10

162.77

1.3

1.2

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

897

1929

2.87

159.80

3.0

2.5

u/ml

1152.3

591.8

0.23

878

1784

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1243

3169

2.43

159.65

1.4

1.3

mg/l

465.8

570.8

3.63

1199

3037

(3024928) Oxygen saturation in Venous blood

1181

2939

2.49

159.53

3.8

2.9

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

13585

66775

1.36

158.46

4.9

3.1

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

691

1276

3.33

157.59

1.5

1.3

g/l

6.3

7.0

3.36

584

751

(3024139) IgG subclass 3 [Mass/volume] in Serum

690

1274

3.33

157.39

1.5

1.3

g/l

0.4

0.35

587

748

(3028192) IgG subclass 2 [Mass/volume] in Serum

690

1274

3.33

157.39

1.5

1.3

g/l

3.0

0.46

584

752

(3000764) Benzodiazepines [Presence] in Urine

2401

7990

1.88

157.25

3.4

1.7

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

381

434

5.38

156.66

2.1

1.5

umol/l

2.0

0.06

353

407

(3028300) Cannabinoids [Presence] in Urine

2415

8083

1.87

155.36

3.4

1.7

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1124

2775

2.51

154.28

1.4

1.2

mmol/l

3.7

0.30

1067

2623

(4198724)

425

546

4.77

154.26

3.7

1.6

—

(3027008) Opiates [Presence] in Urine

2403

8060

1.87

153.52

3.2

1.6

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

751

1490

3.10

153.16

6.3

5.4

mg/l

11.1

11.2

0.21

687

1365

(4024509)

514

784

4.03

152.54

1.5

—

(4062490)

681

1273

3.29

152.46

1.5

1.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1021

2419

2.61

152.10

1.7

1.6

—

(3026250) Tacrolimus [Mass/volume] in Blood

351

382

5.63

150.85

40.9

32.4

ug/l

7.1

7.5

1.79

321

353

(44806118)

660

1224

3.32

149.54

1.7

1.4

—

(44790049)

660

1225

3.31

149.36

1.7

1.4

—

(44790048)

660

1226

3.31

149.18

1.7

1.4

—

(44790047)

660

1226

3.31

149.18

1.7

1.4

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

612

1083

3.47

148.61

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

612

1083

3.47

148.61

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

611

1082

3.47

148.21

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

607

1074

3.47

147.43

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

606

1072

3.48

147.23

1.2

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

399

506

4.83

146.88

1.5

1.6

ug/l

8.7

7.2

0.52

376

444

(40759836) Histone Ab [Presence] in Serum by Immunoblot

604

1072

3.46

146.04

1.2

—

(3010375) cycloSPORINE [Mass/volume] in Blood

360

416

5.30

145.95

30.2

23.8

ug/l

114.0

126.8

1.51

294

361

(3016879) Cocaine [Presence] in Urine

2224

7392

1.88

145.88

3.5

1.7

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1664

4992

2.07

145.68

2.1

1.8

ug/l

2.7

2.4

0.27

1494

4458

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1407

3968

2.20

143.79

3.4

3.1

mg/l

37.7

44.0

0.82

1287

2899

(3034860) Kappa light chains.free [Mass/volume] in Serum

1410

3980

2.20

143.79

3.4

3.1

mg/l

51.3

63.1

0.63

1291

2907

(3013512) EKG study

8775

40662

1.40

143.11

3.8

3.3

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1366

3842

2.20

140.47

3.4

3.1

ratio

1.8

5.0

0.78

220

(3042111) Morphology [Interpretation] in Bone marrow Narrative

898

2079

2.66

139.79

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

496

798

3.81

137.41

1.8

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

496

798

3.81

137.41

1.8

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

496

798

3.81

137.41

1.8

1.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

963

2338

2.54

136.63

1.3

1.2

u/ml

4.0

3.9

0.15

439

1065

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

962

2373

2.50

132.15

1.4

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1340

3841

2.16

131.50

1.2

1.1

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1191

3251

2.27

131.32

1.4

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1191

3253

2.26

131.13

1.4

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

1172

3180

2.28

131.02

1.7

1.6

e6/l

12603.5

13610.5

0.31

844

2236

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1411

4137

2.11

130.85

2.7

2.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

997

2516

2.45

130.65

1.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1096

2901

2.33

129.56

1.5

1.4

e6/l

1435.6

991.4

0.31

889

2264

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

576

1076

3.29

129.09

1.1

u/ml

53.7

81.9

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1091

2899

2.32

127.85

1.5

1.4

e6/l

27.3

37.8

0.35

866

2121

(3027944) Amphetamines [Presence] in Urine

2292

8026

1.78

126.84

3.1

1.6

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

457

739

3.79

125.77

1.2

u/l

21.1

24.1

0.69

414

630

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

464

760

3.74

125.53

2.7

1.7

95.7

97.7

0.50

443

708

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

557

1041

3.29

124.74

1.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

758

1708

2.73

124.09

1.2

u/ml

39.3

51.1

0.52

112

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2768

10296

1.68

123.78

8.7

6.4

mmol/l

24.9

24.7

1.22

2755

10194

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

462

763

3.71

123.60

1.2

u/l

93.2

86.3

0.63

425

659

(3042733) HLA Ab [Presence] in Serum

300

344

5.33

122.62

4.8

5.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

339

441

4.71

121.44

2.9

2.4

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

640

1330

2.96

120.88

3.4

3.3

nmol/l

6.1

9.0

0.31

626

1298

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

195

134

8.89

120.83

2.6

2.8

u/field

0.6

0.5

0.38

195

134

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1383

4184

2.05

118.08

1.4

1.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

2979

11434

1.63

117.89

1.2

iu/ml

132.0

150.2

1.50

1015

4518

(3016244) Insulin [Units/volume] in Serum or Plasma

451

759

3.64

117.60

3.1

3.0

mu/l

26.8

28.3

0.22

413

726

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

920

2355

2.41

116.92

1.6

1.4

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

773

1818

2.62

116.70

5.2

4.6

umol/l

364.1

363.7

0.02

698

1556

(3023420) DNA double strand Ab [Units/volume] in Serum

736

1688

2.68

116.58

1.6

1.5

iu/ml

29.8

29.3

0.02

(3019832) Treponema pallidum Ab [Presence] in Serum

4792

20539

1.48

116.02

1.9

1.6

—

(40757494) Bilirubin.total [Moles/volume] in Blood

411

653

3.86

115.80

2.2

2.1

umol/l

30.9

50.4

0.95

(3000034) Microalbumin [Mass/volume] in Urine

525

992

3.25

115.63

2.7

2.8

mg/l

44.5

55.5

0.38

368

695

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

485

873

3.41

114.92

1.6

1.3

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

416

672

3.79

114.67

3.0

1.5

—

(3000093) Morphology [Interpretation] in Blood Narrative

581

1186

3.01

113.09

1.1

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

406

651

3.82

113.03

2.4

2.7

u/ml

1052.6

1036.6

0.03

397

645

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

398

633

3.85

112.00

2.5

2.2

e9/l

0.2

0.44

330

531

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

409

665

3.77

111.78

2.5

2.1

e6/l

547.9

511.1

0.65

332

528

(3027273) Bicarbonate [Moles/volume] in Venous blood

1910

6572

1.81

111.63

4.0

2.9

mmol/l

24.9

25.3

5.89

1866

6360

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

802

1971

2.50

110.95

1.3

1.2

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

767

1846

2.56

110.66

1.1

g/l

1.5

0.25

709

1685

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

932

2491

2.31

107.70

1.3

1.2

u/ml

3.2

3.9

0.50

318

889

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

404

670

3.69

107.52

12.0

11.9

mmol/l

0.6

0.35

385

604

(21494890) Protein electrophoresis panel - 24 hour Urine

593

1277

2.85

105.34

2.2

1.9

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

535

1095

3.00

103.69

1.8

1.4

promille

1.6

1.4

2.67

428

817

(40768443) Skin Pathology biopsy report

1861

6496

1.78

103.57

1.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

337

501

4.12

103.37

2.7

1.6

umol/l

137.6

115.1

0.58

185

245

(3000492) Spirometry study

4012

16987

1.49

102.24

1.6

1.4

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

404

698

3.54

101.60

3.3

3.6

nmol/l

99.3

124.3

0.82

398

687

(3029634) Reagin Ab [Titer] in Serum by VDRL

720

1763

2.51

100.35

2.4

1.7

titre

14.0

3.0

1.42

(40760892) CBC W Ordered Manual Differential panel - Blood

8051

38608

1.34

99.84

5.2

3.9

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2122

7773

1.70

99.71

12.0

9.2

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

610

1387

2.70

98.21

1.2

u/l

59.8

71.1

1.49

472

961

(21494434) Karyotype in Bone marrow

485

968

3.07

98.00

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

351

563

3.82

97.73

2.9

2.5

36.1

39.3

1.01

174

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

468

920

3.12

96.91

1.3

1.2

—

(40760888) Immunoglobulin light chains.free panel - Serum

1012

2931

2.13

96.56

3.6

3.1

—

(3000060) B lymphocytes [#/volume] in Blood

245

292

5.13

96.41

2.4

1.7

e6/l

214.6

1467.3

0.79

173

144

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

706

1748

2.48

96.19

1.3

nmol/l

0.6

2.2

1.12

684

1676

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

661

1594

2.55

95.00

1.3

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

700

1740

2.47

94.60

1.3

nmol/l

0.2

0.58

113

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

215

229

5.73

94.44

1.3

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

660

1602

2.53

93.63

2.5

2.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

529

1144

2.84

93.30

1.5

1.3

—

(4306422)

857

2351

2.24

93.25

1.2

—

(4268621)

661

1610

2.52

93.12

2.5

2.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

528

1146

2.83

92.53

1.5

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

527

1144

2.83

92.33

1.5

1.3

—

(3008898) HLA-B27 [Presence]

1638

5695

1.78

92.18

1.1

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

309

471

4.01

91.92

2.3

1.4

umol/l

27.5

29.3

2.01

295

452

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

874

2434

2.21

91.78

1.1

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

333

539

3.78

91.64

1.7

1.3

umol/l

20.3

29.2

4.94

317

510

(3023410) Appearance of Cerebral spinal fluid

606

1425

2.61

91.53

1.7

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

524

1151

2.79

89.90

1.5

1.3

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

792

2135

2.28

89.74

1.2

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

622

1498

2.55

89.64

1.2

—

(3037121) Protein [Mass/volume] in Urine

1263

4080

1.91

89.48

3.1

3.4

g/l

0.3

0.29

676

2030

(3009214) Lutropin [Units/volume] in Serum or Plasma

1487

5070

1.81

89.18

1.4

1.3

u/l

10.0

9.0

1.80

1193

4129

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

310

488

3.88

88.51

1.1

1.0

—

(3003181) Sodium [Moles/volume] in Urine

774

2081

2.29

88.23

1.6

1.4

mmol/l

63.5

62.7

0.17

612

1624

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

604

1445

2.57

88.21

1.9

1.6

titre

7266.2

4869.3

0.24

(3024522) Salmonella sp identified in Specimen by Organism specific culture

524

1167

2.75

87.68

1.5

1.3

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

534

1204

2.72

87.36

3.9

3.7

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

367

663

3.39

86.59

1.5

1.4

u/l

5.8

5.9

0.13

299

564

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

531

1203

2.71

86.10

1.5

1.3

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

267

382

4.27

85.89

2.3

1.7

29.7

29.2

0.18

261

363

(3006245) CD3-CD19+ cells/100 cells in Blood

272

397

4.19

85.42

2.4

1.9

9.5

10.6

0.63

266

374

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

347

618

3.44

83.62

1.4

1.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

347

618

3.44

83.62

1.4

1.3

—

(21494755) Public health laboratory ask at order entry panel

2824

24638

0.67

81.98

1.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

698

1855

2.31

81.69

1.5

1.2

—

(3037756) Immunofixation for Serum or Plasma

862

2504

2.12

81.60

1.6

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

449

955

2.88

81.58

1.1

mg/l

297.9

286.7

1.73

416

866

(3038177) Helicobacter pylori Ab [Presence] in Serum

940

2825

2.05

81.49

1.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1272

4254

1.85

81.04

1.1

u/ml

6.2

4.8

0.42

179

722

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

814

2320

2.16

80.81

1.2

1.1

119.0

117.7

0.45

761

2088

(3049717) Cytology report of Urine Cyto stain

1449

5064

1.77

79.99

2.5

2.7

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

441

942

2.87

79.55

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

654

1710

2.35

79.37

1.2

1.1

95.5

97.0

0.63

625

1605

(40768441) Liver Pathology biopsy report

463

1018

2.79

79.34

1.6

1.2

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

549

1322

2.55

79.18

1.1

au/ml

62.8

63.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

439

938

2.87

79.15

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

614

1562

2.41

79.07

1.5

—

(3024932) HLA-DR beta [Type]

246

355

4.23

78.36

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

465

1033

2.76

78.21

1.1

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

112

10.67

77.76

1.1

u/ml

27.1

20.9

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

112

10.67

77.76

1.1

u/ml

32.5

15.6

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

336

616

3.34

77.61

1.6

1.5

iu/ml

1628363.1

1778442.0

0.08

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1146

3757

1.88

77.61

1.4

—

(3024471) HLA-A [Type]

248

365

4.15

77.14

1.0

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

281

456

3.77

77.14

2.5

1.7

156.3

159.6

0.21

271

420

(3051611) Lipemic interference index of Serum or Plasma

587

1490

2.42

75.97

4.2

3.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

1762

6622

1.65

74.72

1.7

1.6

mu/l

337.5

298.4

1.27

1643

5887

(3002256) Pathology report gross observation

4783

22029

1.36

74.60

1.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

989

3127

1.95

74.52

1.8

1.5

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

759

2174

2.14

74.44

1.5

1.3

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

325

601

3.31

74.13

1.1

nmol/l

1.7

8.8

1.92

142

(3044290) Cell count panel - Cerebral spinal fluid

926

2871

1.98

73.74

1.5

1.3

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

320

588

3.33

73.69

2.8

1.7

142.7

142.3

0.02

310

553

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

820

2435

2.07

73.36

1.1

u/ml

3.8

2.8

0.86

279

1385

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

2007

7831

1.59

73.14

3.0

3.3

u/ml

43.9

49.8

0.37

1925

7585

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

976

3099

1.94

72.65

1.9

1.5

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

376

774

2.97

72.30

1.5

u/ml

23.2

25.7

0.35

154

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

28.82

72.25

1.1

1.0

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

533

1326

2.46

71.97

1.9

1.8

mg/l

24.4

29.0

0.86

140

413

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

190

240

4.83

70.47

1.2

1.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

721

2072

2.14

70.14

1.2

1.1

—

(3051651) Icteric interference index of Serum or Plasma

382

813

2.87

69.41

4.6

3.5

—

(21494815) CD4 cells/100 lymphocytes in Specimen

451

1055

2.62

68.91

2.1

2.0

42.0

40.8

0.15

(3004616) Nuclear Ab [Presence] in Serum

508

1263

2.46

68.71

1.4

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

434

997

2.66

68.65

3.0

2.3

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

248

402

3.77

68.25

1.2

g/l

0.3

0.13

217

311

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

234

363

3.94

68.20

1.2

111.3

110.1

0.25

210

325

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

445

1048

2.60

67.12

1.5

1.4

umol/l

12.4

11.9

0.66

420

1002

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1099

3730

1.81

66.74

1.9

iu/l

21.3

23.8

0.04

320

1418

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

182

233

4.77

66.56

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

324

642

3.09

66.39

1.3

1.2

titre

78.7

104.6

0.28

(3011412) CD3 cells [#/volume] in Blood

459

1110

2.53

65.71

2.5

2.1

e9/l

1.3

1.1

3.11

254

745

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1271

4542

1.72

64.85

2.2

1.7

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

405

929

2.67

64.27

2.4

2.2

nmol/l

20.0

18.9

1.09

384

896

(3024263) Appearance of Synovial fluid

323

652

3.03

64.23

1.4

1.5

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

718

2135

2.06

64.03

1.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1467

13972

0.62

63.86

4.6

3.7

mmol/l

1.2

0.55

1341

11919

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

328

673

2.98

63.48

1.3

1.2

titre

421.6

498.2

0.10

(3017354) Segmented neutrophils/100 leukocytes in Blood

390

884

2.70

63.30

3.2

2.9

58.9

58.8

0.03

238

607

(3041096) Erythrocytes [Presence] in Urine by Automated

6685

49408

0.79

62.83

3.4

2.8

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

2087

8506

1.52

62.53

1.4

1.3

iu/l

25.2

27.3

2.05

1801

7213

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

488

1248

2.39

62.23

1.6

1.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

776

2402

1.98

62.09

1.9

1.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1281

4658

1.69

61.38

1.2

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

291

567

3.14

61.30

6.8

4.0

mg/l

1229.8

4404.6

1.49

246

396

(3016018) Differential panel - Cerebral spinal fluid

576

1596

2.21

61.29

1.5

1.4

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

224

366

3.74

61.04

2.7

2.2

—

(3003694) ABO and Rh group [Type] in Blood

10420

54329

1.23

59.91

1.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

713

2170

2.02

59.78

1.2

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

770

2412

1.96

59.59

1.2

1.1

au/ml

9.5

11.8

0.44

194

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

686

2063

2.04

59.40

1.3

1.2

u/l

47.4

28.1

2.46

627

1783

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

200

309

3.95

58.67

2.1

1.5

u/l

27.0

33.8

0.37

187

274

(3042517) Benzodiazepines panel - Urine

122

118

6.30

58.59

3.2

3.9

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

470

1215

2.37

58.58

1.1

—

(3045142) Bone marrow Pathology biopsy report

523

1423

2.25

58.10

1.3

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

411

1002

2.51

57.94

1.2

1.1

mg/l

35.7

45.6

3.61

374

802

(4146454)

286

576

3.03

57.15

3.0

1.9

—

(3029075) Extractable nuclear Ab panel - Serum

233

411

3.46

57.11

1.1

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

135

151

5.45

56.78

1.4

1.5

nmol/l

109532.4

460473.4

0.94

105

129

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

240

435

3.37

56.54

1.3

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

11.19

56.40

1.1

—

(4094501)

1144

4128

1.71

56.35

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

394

954

2.53

56.34

1.1

mg/l

229.2

265.1

3.19

368

823

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

766

2443

1.92

56.31

1.3

1.2

titre

248.3

99.5

0.71

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

140

165

5.17

55.92

6.9

4.9

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1152

4185

1.69

55.36

2.0

1.6

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

150

193

4.74

54.65

1.9

2.0

umol/l

17.2

17.5

0.11

150

193

(3044941) Cell count panel - Synovial fluid

734

2337

1.93

54.23

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

744

2383

1.92

54.02

1.6

1.4

—

(3034426) Prothrombin time (PT)

244

463

3.22

53.65

1.3

1.2

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

372

905

2.51

52.72

14.7

11.3

nmol/l

849.1

1932.0

0.49

363

870

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1127

4136

1.68

52.16

4.9

2.8

mg/l

1.5

1.86

1057

3820

(3010144) Erythrocytes [#/volume] in Synovial fluid

461

1253

2.25

51.40

1.4

1.3

e6/l

106678.1

91250.4

0.21

355

865

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

623

1914

1.99

50.96

1.6

1.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

287

621

2.82

50.80

1.4

1.3

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

375

933

2.46

50.78

1.2

1.1

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

378

953

2.43

49.79

18.8

16.3

nmol/l

1461.2

2983.6

0.47

369

917

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

321

747

2.63

49.69

2.2

1.6

u/field

2.3

2.4

0.08

283

592

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

7.66

49.43

1.5

1.7

mg/l

1.5

1.6

0.01

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

7.66

49.43

1.5

1.7

mg/l

1.3

2.0

0.46

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

7.66

49.43

1.5

1.7

mg/l

1.5

3.8

1.47

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

7.66

49.43

1.5

1.7

mg/l

3.8

0.02

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

7.66

49.43

1.5

1.7

mg/l

1.0

2.1

1.30

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

7.66

49.43

1.5

1.7

mg/l

0.4

0.6

0.48

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

7.66

49.43

1.5

1.7

mg/l

1.3

2.2

0.58

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

7.66

49.43

1.5

1.7

mg/l

1.4

3.3

1.20

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

7.66

49.43

1.5

1.7

mg/l

1.8

1.1

0.62

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

7.53

49.38

1.5

1.7

mg/l

1.5

1.9

0.25

(3045424) Erythrocytes [Presence] in Urine

681

2188

1.91

49.03

1.5

1.4

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

126

153

5.02

48.87

1.2

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

255

528

2.95

48.74

1.2

—

(3001186) Copper [Moles/volume] in Serum or Plasma

174

280

3.79

48.51

1.5

1.2

umol/l

16.9

16.6

0.26

156

249

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

386

996

2.37

48.40

1.3

1.2

u/ml

0.7

1.4

0.88

190

327

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

322

762

2.58

48.27

1.2

u/ml

74.6

65.6

0.16

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

374

953

2.40

48.18

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

322

765

2.57

47.90

1.2

u/ml

46.7

47.0

0.01

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

926

3308

1.72

47.29

1.6

1.4

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

441

1220

2.21

47.21

1.3

nmol/l

1.4

0.02

396

1107

(3028433) Virus identified in Specimen by Culture

191

336

3.47

47.10

1.2

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

338

830

2.49

47.06

1.3

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

339

837

2.47

46.68

1.3

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

349

879

2.43

46.11

2.3

1.9

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

188

332

3.45

46.11

1.9

1.4

u/ml

1257.0

1858.0

0.21

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

9.40

45.84

2.6

1.2

—

(3011897) Casein IgE Ab [Units/volume] in Serum

145

212

4.17

45.68

1.2

1.3

u/ml

8.0

6.9

0.05

(44813793)

405

1097

2.26

45.58

1.1

—

(1175426) CD3 cells/100 lymphocytes in Blood

361

930

2.37

45.46

2.2

1.9

74.1

72.3

1.33

349

901

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

460

1316

2.14

45.40

4.0

5.1

u/ml

190.5

98.3

0.92

113

459

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

306

730

2.56

45.18

1.2

u/ml

10.2

8.3

0.10

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

259

568

2.78

44.83

1.2

—

(3014271) Vancomycin [Susceptibility]

214

420

3.11

44.72

2.9

2.7

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

173

3009

0.35

44.61

2.6

2.2

13.1

0.03

167

2963

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

220

440

3.05

44.59

1.1

87.1

92.3

1.04

195

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

297

704

2.58

44.42

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

354

918

2.36

43.96

2.2

1.9

13.5

13.8

0.16

253

351

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

220

445

3.02

43.79

1.2

109.1

106.7

0.33

203

401

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

350

905

2.36

43.74

2.0

1.6

—

(4035726)

3048

14153

1.34

43.59

1.4

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

885

3199

1.70

43.34

1.1

u/ml

4.8

5.7

0.94

509

1564

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

510

1547

2.02

43.26

1.2

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

214

431

3.03

42.91

1.1

1.2

85.2

92.8

1.26

195

(3008757) Leukocyte morphology finding [Identifier] in Blood

419

1183

2.17

42.76

3.6

3.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

255

572

2.72

42.39

1.1

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

301

736

2.50

42.34

1.2

1.1

iu/ml

3.4

4.3

0.73

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

174

310

3.42

42.19

1.5

1.3

105.9

107.8

0.27

168

288

(4027681)

314

786

2.44

42.08

1.2

1.3

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

439

1274

2.11

41.84

1.5

—

(3023419) Bacteria identified in Sputum by Culture

506

1553

1.99

41.59

2.5

2.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

6.87

40.91

1.2

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

333

872

2.33

40.52

1.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

352

4406

0.48

40.34

3.6

3.0

mg/l

20.2

27.4

4.18

174

2891

(3012494) Peanut IgE Ab [Units/volume] in Serum

198

396

3.05

40.19

1.1

u/ml

2.1

7.2

1.21

125

228

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

5.95

39.89

1.2

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

163

289

3.44

39.83

1.2

71.2

80.6

0.93

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

165

296

3.40

39.64

1.2

84.0

91.1

0.61

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

200

407

3.00

39.47

1.4

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

200

408

2.99

39.31

1.4

1.3

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

370

1030

2.20

39.12

2.1

1.6

mg/l

3.5

3.8

0.44

354

974

(3011985) Renin [Units/volume] in Plasma

576

1893

1.86

38.82

1.6

1.5

mu/l

69.7

67.7

0.06

531

1692

(3016038) Potassium [Moles/volume] in Urine

310

802

2.36

38.77

1.5

1.2

mmol/l

36.7

35.3

0.40

264

699

(3021788) Differential panel - Synovial fluid

778

2800

1.70

38.74

1.6

1.5

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

286

713

2.45

38.71

1.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

182

355

3.13

38.49

2.1

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

182

355

3.13

38.49

2.1

1.9

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

184

362

3.10

38.39

2.1

1.9

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

954

3631

1.61

38.35

1.1

u/ml

1.2

1.9

2.09

429

1386

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

4257

21010

1.26

38.06

1.8

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

470

1454

1.98

37.84

1.3

nmol/l

19.8

22.0

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

655

2259

1.78

37.83

3.4

2.9

nmol/l

0.8

0.22

524

1790

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

230

522

2.69

37.48

1.4

mu/l

524.3

859.8

0.79

220

500

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

118

174

4.13

36.89

1.8

1.2

ng/l

72.2

98.7

0.33

116

(3008295) Osmolality of Serum or Plasma

432

1311

2.01

36.69

1.5

1.4

mosm/kgh2o

280.6

279.5

0.40

313

1035

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

311

833

2.28

36.04

1.9

1.5

u/l

4.7

6.9

1.37

200

420

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

129

208

3.78

36.00

1.6

1.4

ug/l

0.4

0.5

1.77

140

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

231

537

2.62

36.00

1.4

72.7

72.9

0.07

221

515

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

669

2357

1.74

35.95

3.6

3.3

u/ml

27.5

40.8

2.43

644

2267

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

159

300

3.23

35.47

1.2

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

449

4993

0.54

35.40

1.4

1.5

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

188

395

2.90

35.21

1.8

1.3

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

5.73

35.01

2.0

1.6

umol/l

1.3

0.10

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

156

294

3.23

34.87

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

205

456

2.74

34.72

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

888

3405

1.60

34.65

2.3

2.4

ug/min

138.8

115.5

0.59

501

2028

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

296

790

2.29

34.60

1.3

1.2

umol/l

4.8

5.5

2.23

268

743

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

133

4.53

34.55

1.1

1.0

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

262

664

2.41

34.32

2.1

2.3

ug/l

39.9

294.6

0.95

253

632

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

593

2045

1.77

34.31

1.8

1.4

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

158

304

3.17

34.21

1.2

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

825

3117

1.62

34.19

1.1

u/ml

0.9

1.2

1.08

403

1240

(3032057) Clostridioides difficile [Presence] in Stool

111

166

4.07

34.14

2.2

1.8

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

157

302

3.17

34.01

1.1

—

(4211845)

298

806

2.26

33.81

2.7

2.4

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

159

310

3.13

33.72

1.6

1.5

ug/l

9.2

9.1

0.04

159

310

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

269

697

2.36

33.61

1.1

u/l

1.1

0.55

331

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

146

270

3.30

33.61

2.9

2.7

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

260

665

2.39

33.41

3.5

3.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

678

2449

1.70

33.37

2.4

2.2

umol/l

6.3

6.2

0.07

507

1794

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

337

966

2.13

33.26

1.7

1.8

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

130

4.50

33.22

1.1

1.0

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

198

443

2.73

33.20

1.4

1.3

57.4

56.4

0.12

171

381

(3037692) Legionella sp identified in Specimen by Organism specific culture

173

359

2.94

33.13

1.9

1.3

—

(3020393) Adenovirus Ag [Presence] in Stool

111

4.83

32.93

1.5

1.1

—

(3044927) Protein electrophoresis panel - Urine

333

954

2.13

32.92

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

2850

13629

1.29

32.62

2.4

2.0

nmol/l

12.1

12.8

4.21

2492

12298

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

140

257

3.32

32.60

1.2

pmol/l

344.5

331.4

0.08

122

198

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

405

1256

1.97

32.46

1.7

—

(40768446) Kidney Pathology biopsy report

222

534

2.54

32.42

1.9

1.5

—

(3008536) Aspergillus sp Ab [Presence] in Serum

119

196

3.70

32.33

1.9

2.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

492

1640

1.83

31.83

1.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

200

463

2.63

31.49

2.1

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

200

463

2.63

31.49

2.1

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

200

463

2.63

31.49

2.1

1.7

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

140

4.22

31.19

1.7

1.6

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

146

284

3.13

31.12

1.2

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

199

463

2.62

31.04

2.1

1.7

—

(37021550) Renin [Units/volume] in Plasma --upright

122

211

3.52

31.01

1.2

1.3

mu/l

68.0

66.6

0.03

166

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

210

503

2.55

30.95

1.1

u/ml

8.7

7.9

0.11

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

224

554

2.47

30.94

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

263

701

2.29

30.90

1.6

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

343

1020

2.05

30.85

1.4

1.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

103

158

3.97

30.74

2.0

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

764

2909

1.61

30.73

3.4

1.6

nmol/l

0.9

0.8

1.03

645

2560

(3025130) Human papilloma virus identified in Specimen

682

2526

1.65

30.60

1.7

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

238

610

2.38

30.50

4.0

2.9

mg/l

8.3

8.4

0.13

210

459

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

143

4.13

30.42

1.6

1.3

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

252

665

2.31

30.30

1.0

ng/l

37.7

41.9

1.00

161

518

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

252

666

2.31

30.20

1.0

ng/l

741.5

719.3

0.32

162

503

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

250

660

2.31

30.03

1.0

ng/l

296.2

330.2

0.94

164

523

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

300

859

2.13

29.75

1.2

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

220

551

2.44

29.63

3.1

2.3

au/ml

113.4

146.1

0.43

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

311

905

2.10

29.61

1.5

1.4

u/l

13.0

12.4

0.66

303

881

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

472

1595

1.81

29.27

1.1

1.0

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

302

878

2.10

28.84

1.3

1.2

u/l

200.9

389.9

2.93

277

831

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

514

1791

1.75

28.80

1.3

pmol/l

428.8

277.1

1.72

415

1425

(3006462) Nitrate [Presence] in Urine

266

737

2.20

28.61

2.8

2.5

—

(3020876) Protein [Mass/time] in 24 hour Urine

353

1092

1.97

28.57

1.8

2.0

g/24h

0.7

0.9

0.22

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

154

3.88

28.39

1.3

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

240

639

2.29

28.32

1.1

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

117

210

3.39

28.24

1.3

nmol/l

0.2

0.3

0.20

140

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

172

390

2.69

28.23

1.4

pmol/l

15.7

15.0

0.34

143

337

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

576

5649

0.61

28.14

1.9

1.8

—

(3023199) Leukocytes [#/volume] in Pleural fluid

477

1639

1.78

28.03

1.5

1.4

e6/l

4125.4

2774.7

0.33

372

1108

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

196

480

2.49

27.69

2.0

1.9

—

(21491868) Cryoglobulin [Mass/volume] in Serum

195

479

2.48

27.39

1.2

1.1

g/l

0.7

0.2

0.50

(3023487) Leukocytes [#/volume] in Peritoneal fluid

190

461

2.51

27.36

2.7

1.6

e6/l

982.0

4528.1

0.84

133

283

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

105

179

3.57

27.29

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

207

527

2.40

26.99

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

286

836

2.09

26.98

1.2

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

226

602

2.29

26.68

1.4

1.3

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

6113

32309

1.18

26.54

1.6

1.7

pmol/l

31332144.8

35476827.0

0.24

5279

26784

(3033923) Metanephrine [Moles/time] in 24 hour Urine

112

204

3.34

26.49

1.1

umol/24h

0.7

0.9

0.41

106

(3028626) Oxygen [Partial pressure] in Capillary blood

865

3508

1.51

26.46

5.0

2.9

kpa

8.6

8.3

2.95

835

3340

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

316

971

1.99

26.11

1.1

iu/ml

8.8

9.0

0.06

286

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

222

594

2.28

25.96

1.4

1.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

190

475

2.44

25.77

3.6

2.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

190

475

2.44

25.77

3.6

2.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1788

14083

0.76

25.75

1.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

2787

20775

0.80

25.45

1.6

1.7

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

125

4.04

25.43

1.3

40.2

54.5

1.45

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

5.37

25.13

1.3

1.4

45.8

35.6

0.74

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

648

2493

1.59

25.06

1.1

1.2

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

890

3683

1.48

24.72

2.0

1.8

pmol/l

186.3

200.9

3.42

844

3515

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

712

2810

1.55

24.69

3.0

3.9

u/ml

200.3

1023.3

2.43

660

2570

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

9.79

24.55

4.4

1.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

437

1524

1.75

24.50

1.5

1.4

e6/l

50378.0

49953.1

0.01

311

839

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1235

5454

1.39

24.12

1.9

1.6

nmol/l

41.3

40.3

0.67

1206

5371

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

172

425

2.47

23.94

2.7

1.5

e6/l

20049.5

10067.6

0.43

104

199

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

558

2096

1.63

23.82

1.5

1.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

629

2433

1.58

23.81

1.3

1.2

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

192

502

2.33

23.70

1.1

ng/l

619.3

526.3

0.11

133

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

168

3.44

23.51

2.6

1.6

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

145

3.65

23.40

1.0

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

213

587

2.21

23.32

1.7

1.5

nmol/l

25.1

4.9

0.43

193

492

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

140

3.70

23.23

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

232

664

2.13

23.17

2.4

2.2

ug/min

78.7

124.2

0.43

135

(3010370) Gastrin [Moles/volume] in Serum or Plasma

174

3.36

22.94

2.0

1.6

pmol/l

39.8

54.6

0.69

145

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

354

1185

1.82

22.77

2.2

1.9

u/field

2.9

1.9

2.31

267

478

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

154

3.52

22.74

1.0

1.2

u/ml

0.4

0.6

0.16

(3012501) Base excess in Blood by calculation

462

4535

0.61

22.72

5.0

3.6

mmol/l

2.3

2.5

0.56

309

3053

(3013290) Carbon dioxide [Partial pressure] in Blood

462

4535

0.61

22.72

5.0

3.6

kpa

5.0

0.15

449

4439

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

9.85

22.65

4.3

1.2

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

107

210

3.10

22.64

1.1

1.2

u/ml

10.3

12.2

0.12

150

(3036603) Volume of Urine

309

992

1.90

22.60

1.7

1.6

1713.1

1962.9

1.10

190

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

838

3497

1.47

22.36

1.5

1.4

pmol/l

141.6

131.2

0.15

815

3429

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

162

3.42

22.33

5.0

2.5

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1603

7461

1.32

22.28

2.1

1.8

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

233

679

2.09

22.26

1.1

miu/ml

1660.5

1449.5

1.80

233

679

(4015189)

114

237

2.93

21.95

2.3

2.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

758

3114

1.49

21.88

1.1

u/ml

1.6

2.4

1.22

177

770

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

196

537

2.22

21.80

2.7

1.8

mg/l

9.3

9.5

0.12

166

406

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4.46

21.75

1.3

1.1

nmol/l

15.0

13.3

0.35

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

166

424

2.39

21.61

1.9

1.6

au/ml

146.3

132.7

0.10

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

5.20

21.56

1.2

1.4

11.0

14.2

0.52

(3004809) Band form neutrophils/100 leukocytes in Blood

516

1952

1.62

21.47

3.3

2.9

1.1

1.5

1.67

391

1598

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

168

433

2.36

21.45

1.3

1.2

—

(3027315) Oxygen [Partial pressure] in Blood

472

4547

0.63

21.41

5.0

3.7

kpa

8.7

0.12

459

4451

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

131

299

2.67

21.38

1.2

1.1

—

(3036180) Methadone [Presence] in Urine

13.69

21.31

2.2

1.8

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

13.69

21.31

6.4

1.1

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

165

3.32

21.18

5.1

2.5

mg/l

22.4

23.2

0.19

155

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

344

1169

1.80

21.12

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

113

3.88

21.01

1.1

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

103

4.02

20.76

1.1

u/ml

2.8

3.5

0.12

(3006270) Folate [Moles/volume] in Blood

339

1158

1.79

20.48

1.2

1.1

nmol/l

367.2

395.3

1.56

294

970

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

4.67

20.37

1.0

u/ml

0.0

0.1

0.55

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

488

1848

1.61

20.25

1.5

1.3

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

156

400

2.38

20.18

1.5

1.4

—

(3018133) Calcium [Moles/volume] in Urine

168

3.23

20.07

2.3

1.7

mmol/l

2.8

2.6

0.21

151

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

729

6350

0.69

20.07

1.4

1.6

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

192

542

2.16

19.93

1.3

1.2

—

(40757373) Influenza virus identified in Isolate

100

204

2.98

19.93

2.0

1.5

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1346

6212

1.33

19.87

1.4

1.5

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

154

3.32

19.80

1.0

—

(3045788) Cell count panel - Pleural fluid

377

1343

1.71

19.74

1.6

1.5

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

172

466

2.25

19.69

2.7

2.8

umol/l

29.1

28.3

0.35

128

352

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

471

1781

1.62

19.68

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1345

6218

1.33

19.63

1.4

1.5

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

4049

21162

1.18

19.62

1.5

1.4

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

105

3.88

19.62

2.2

1.9

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

688

2835

1.48

19.62

1.4

nmol/l

0.5

0.4

0.45

532

2260

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1337

6180

1.33

19.53

1.4

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

4.17

19.52

1.1

1.3

ml/s/173m2

1.4

1.2

0.46

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

168

3.19

19.51

1.6

1.4

ng/l

114.9

117.6

0.05

168

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

4.48

19.49

1.4

1.3

pmol/l

15.6

16.4

0.11

(3050129) First trimester maternal screen panel - Serum or Plasma

1583

7500

1.30

19.34

1.6

1.4

—

(3030313) Adrenal Ab [Titer] in Serum

112

3.75

19.30

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1337

6203

1.32

19.04

1.4

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

5.81

19.00

10.7

9.9

e6/l

135.7

211.1

0.63

(3003434) Protein [Mass/volume] in Pleural fluid

487

1873

1.59

19.00

1.5

1.4

g/l

32.7

33.7

0.86

444

1686

(3002619) Bacteria identified in Specimen by Culture

127

305

2.54

18.85

1.3

1.2

—

(3044007) Cell count panel - Peritoneal fluid

156

413

2.30

18.85

2.3

1.7

—

(1002224) Polysomnography panel

1651

7892

1.28

18.83

1.1

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1571

7462

1.29

18.83

2.5

2.4

e6/l

0.3

0.38

1493

7234

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

291

975

1.82

18.77

1.3

1.2

mmol/l

2.1

0.10

270

912

(3028271) Lactate [Moles/volume] in Capillary blood

295

3081

0.58

18.72

2.2

1.7

mmol/l

1.7

1.8

0.36

286

3008

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

147

382

2.34

18.52

1.1

1.0

u/ml

6.4

11.1

0.79

(3002331) Protein [Mass/volume] in Peritoneal fluid

121

287

2.57

18.42

1.4

1.3

g/l

24.9

47.1

0.59

230

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

114

263

2.64

18.31

2.0

1.8

ug/l

2.3

4.4

0.63

173

(3007463) Buprenorphine [Presence] in Urine

5.25

18.11

3.8

12.4

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

4.61

17.98

1.4

1.5

u/field

1.3

1.2

0.30

(40767503) Oxygen content in Capillary blood by calculation

427

4041

0.64

17.94

2.7

2.3

16.5

16.6

0.25

251

1912

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

137

352

2.37

17.72

1.1

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

111

3.62

17.64

1.0

1.1

u/ml

1.2

11.3

1.47

(3015235) Bicarbonate [Moles/volume] in Capillary blood

791

3422

1.41

17.51

3.2

2.9

mmol/l

24.4

24.8

2.32

744

3133

(3018001) Oat IgE Ab [Units/volume] in Serum

4.33

17.45

1.0

u/ml

0.5

0.3

0.17

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1458

6929

1.29

17.42

1.9

1.6

mg/l

3.6

3.3

0.48

1112

4605

(3033799) Differential panel - Peritoneal fluid

158

437

2.20

17.31

2.4

1.7

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

441

1700

1.58

17.10

2.1

1.8

ug/l

24.5

27.3

0.32

426

1680

(3022229) Phosphate [Moles/volume] in Urine

5.31

17.07

2.9

1.7

mmol/l

22.0

21.5

0.04

(3045716) Anion gap in Serum or Plasma

131

336

2.37

17.03

2.0

2.5

mmol/l

8.0

9.7

3.94

102

190

(3019977) pH of Arterial blood

265

890

1.82

17.02

3.2

2.3

7.4

0.07

365

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.88

17.01

2.4

2.1

—

(3047189) Immunofixation for 24 hour Urine

201

617

1.99

16.87

1.6

1.9

—

(3009871) Measles virus Ab [Titer] in Serum

170

495

2.09

16.43

1.5

1.7

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

130

340

2.33

16.22

2.1

1.2

g/l

12.8

13.4

0.26

255

(3018851) Theophylline [Moles/volume] in Serum or Plasma

4.06

16.15

2.2

1.6

umol/l

47.6

43.2

0.40

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

4.26

16.14

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

280

976

1.75

15.94

1.1

1.2

ratio

1.1

0.61

452

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

191

2.80

15.87

1.0

1.8

—

47.0

—

(3042951) Complement C1q Ab [Units/volume] in Serum

4.67

15.73

1.2

1.4

u/ml

25.4

23.6

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

136

370

2.24

15.54

1.2

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

157

2.99

15.47

1.4

1.5

—

(3036670) Protein [Mass/volume] in Synovial fluid

126

333

2.30

15.39

1.3

1.2

g/l

40.2

40.7

0.14

186

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

121

314

2.35

15.39

1.4

1.2

nmol/l

124.9

125.1

0.00

220

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

138

380

2.21

15.34

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

172

518

2.02

15.27

7.8

13.5

—

(40765096) Chromosome analysis panel by Banding

123

323

2.32

15.24

1.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2664

19016

0.84

15.22

3.5

3.2

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

125

331

2.30

15.21

1.1

mg/g

6.7

6.1

0.54

120

318

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

4.56

14.98

1.2

1.3

1.6

1.0

0.37

(3010421) pH of Blood

595

5080

0.71

14.70

4.7

3.6

7.4

2.77

451

4444

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

186

588

1.93

14.45

2.3

umol/l

49.3

52.0

0.54

154

482

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

122

3.19

14.34

1.4

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

214

711

1.83

14.32

1.1

95.4

95.9

0.10

173

547

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

852

3873

1.34

14.05

1.2

1.3

—

(3010838) Calcium [Moles/time] in 24 hour Urine

203

668

1.85

14.01

1.5

mmol/24h

4.8

5.6

0.35

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

160

2.85

14.00

1.3

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

191

2.68

13.98

1.7

1.5

—

(3020491) Glucose [Moles/volume] in Blood

309

1153

1.63

13.79

2.0

1.9

mmol/l

6.5

6.7

0.64

262

923

(3037556) Urate [Mass/volume] in Serum or Plasma

117

315

2.26

13.76

1.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

244

857

1.74

13.62

6.6

7.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1357

6596

1.26

13.57

1.4

1.5

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

163

2.80

13.57

3.6

2.8

umol/l

41.8

45.8

0.72

144

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

114

3.20

13.54

1.2

1.1

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

176

2.70

13.20

3.2

2.4

pmol/l

77.3

70.7

0.13

156

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

196

651

1.83

13.18

1.2

1.3

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

123

3.07

13.09

3.1

2.1

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

120

3.09

13.05

1.3

1.2

mg/l

46.7

47.4

0.04

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

207

703

1.79

12.97

6.8

4.5

u/ml

15599.6

1496.1

0.48

101

(3020123) Porphyrins [Interpretation] in Serum or Plasma

4.24

12.83

1.1

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

225

788

1.74

12.72

1.2

1.1

iu/ml

200.3

216.6

0.30

225

778

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

107

288

2.26

12.64

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

212

733

1.76

12.53

1.2

1.3

—

(3025315) Body weight

120

3.04

12.52

4.8

3.9

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

3.70

12.51

1.1

—

610.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

164

2.71

12.48

2.0

2.7

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

3.65

12.29

4.4

2.7

pmol/l

91.0

54.0

0.28

(3043410) Blood group antigens tested for on Red Blood Cells

131

388

2.06

12.26

1.9

1.7

—

(3014891) Appearance of Pleural fluid

142

2.83

12.20

1.4

1.5

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

108

299

2.20

11.97

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

108

301

2.18

11.79

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

306

1192

1.56

11.54

1.1

u/ml

3.5

2.0

0.29

114

323

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

107

301

2.16

11.44

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

117

343

2.08

11.29

1.2

1.1

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

3.48

11.27

1.0

1.1

u/ml

0.2

3.9

2.00

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1062

0.46

11.23

1.9

1.5

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

584

2596

1.37

11.21

1.1

iu/ml

71.4

752.3

1.02

107

568

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

109

3.01

11.15

1.1

1.2

umol/24h

1.6

1.7

0.46

109

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

224

2.34

11.00

1.1

1.0

ug/l

79.2

78.9

0.03

190

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

124

376

2.01

10.96

2.4

1.9

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

105

299

2.14

10.92

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

162

2.59

10.92

1.0

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

162

540

1.83

10.87

2.4

2.3

nmol/l

139.7

149.0

0.57

152

439

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

8010

45238

1.10

10.85

1.6

mmol/l

1.4

4.46

7344

37106

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

1063

0.47

10.79

1.8

1.5

—

(4034850)

914

7011

0.79

10.71

13.5

8.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

120

2.84

10.48

1.1

—

(3017704) Immunofixation for Urine

160

538

1.81

10.46

1.8

1.5

—

(3017509) Phencyclidine [Presence] in Urine

203

2.37

10.43

2.7

1.5

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

309

1242

1.52

10.20

1.3

u/l

780.6

514.5

0.49

293

1179

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

116

2.83

10.08

1.0

1.1

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

3.83

9.95

1.0

u/ml

0.1

2.2

0.57

(3010503) CD19 cells [#/volume] in Blood

204

748

1.66

9.90

2.6

2.2

e9/l

0.2

0.3

0.15

196

731

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

151

508

1.81

9.89

1.2

1.1

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

167

2.48

9.89

1.6

ug/l

111.0

110.8

0.01

135

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

4.79

9.86

1.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

4.79

9.86

6.5

4.5

—

(3009015) Lactate [Moles/volume] in Synovial fluid

3.08

9.85

1.4

1.3

mmol/l

5.9

0.00

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

3.97

9.81

1.0

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

118

2.78

9.79

1.1

—

(3020650) Glucose [Presence] in Urine

664

0.37

9.77

1.7

1.3

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

4.15

9.69

1.1

nmol/l

279.0

265.3

0.10

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.39

9.68

1.4

1.1

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

3.45

9.67

1.8

1.4

umol/l

0.7

0.06

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

155

2.51

9.58

1.2

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

208

2.28

9.53

1.1

—

(4212803)

127

2.68

9.51

1.1

1.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

140

1476

0.58

9.49

1.8

1.4

—

(44806071)

167

2.44

9.47

1.0

1.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

153

2.51

9.39

2.1

2.0

mmol/l

0.7

1.6

2.62

121

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

139

465

1.82

9.30

2.9

2.5

ug/l

1.3

1.2

0.33

129

435

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

199

2.29

9.28

1.9

1.4

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

2.95

9.21

1.0

1.1

u/ml

10.7

5.8

0.20

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

148

2.51

9.12

1.2

1.1

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

5.00

9.11

1.2

1.0

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

291

1185

1.50

9.09

1.1

u/ml

2.0

4.0

0.38

278

(3027923) C peptide [Moles/volume] in Serum or Plasma

160

563

1.73

9.07

1.7

1.6

nmol/l

1.3

1.2

0.17

116

475

(3012441) Differential panel - Pleural fluid

360

1530

1.43

9.06

1.5

1.4

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

283

2.04

8.90

1.2

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

2.91

8.86

1.0

1.2

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

2.94

8.81

1.2

1.5

u/ml

1.2

9.3

0.61

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.85

8.56

1.8

1.2

umol/24h

323.0

317.6

0.05

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

288

1187

1.48

8.52

1.2

1.1

—

(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid

3.91

8.16

4.5

5.5

mmol/l

19.8

18.0

0.49

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

3.23

8.13

3.7

3.1

—

(3048879) Bone marrow aspiration report

236

2.09

8.08

2.1

1.5

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

269

2.01

8.07

1.3

1.4

nmol/l

5.1

5.9

1.08

260

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

966

4802

1.23

8.07

1.9

1.6

—

(40768806) Pleura Pathology biopsy report

356

1546

1.40

8.01

1.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

486

3875

0.76

7.87

1.5

1.6

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

109

1161

0.57

7.78

1.7

1.4

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

2.83

7.75

1.0

1.1

u/ml

0.2

1.1

0.87

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

131

2.46

7.70

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

481

2207

1.33

7.69

1.1

1.0

u/ml

0.2

0.6

1.60

131

406

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

2.72

7.59

1.0

1.1

u/ml

0.8

1.2

0.17

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

3.77

7.51

8.3

—

(3006576) Bicarbonate [Moles/volume] in Blood

133

472

1.72

7.41

6.7

5.4

mmol/l

24.5

25.0

0.63

126

417

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

243

2134

0.69

7.32

2.2

32.3

32.7

0.80

243

2117

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

774

3801

1.24

7.29

1.8

1.6

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.71

7.19

1.2

1.4

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

174

671

1.58

7.07

1.2

1.1

u/l

29.3

23.4

0.48

140

526

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.76

7.06

1.2

1.5

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.68

7.06

1.0

1.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

174

672

1.58

7.03

1.2

1.1

u/l

100.2

83.0

0.99

147

541

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

407

1854

1.34

6.89

2.0

1.5

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

4.34

6.87

1.0

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

565

2707

1.27

6.62

1.1

1.0

u/ml

4.0

4.7

0.43

226

1017

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

3.99

6.54

1.1

1.6

—

(3033942) Copper [Moles/time] in 24 hour Urine

3.28

6.50

1.5

1.1

umol/24h

2.5

0.4

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

3.28

6.50

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

124

2.35

6.43

1.1

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

129

2.31

6.30

6.6

6.8

—

(3001556) Androgen free Index in Serum or Plasma

133

2.29

6.29

1.4

1.2

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

3.59

6.27

1.0

pmol/l

213.0

222.1

0.03

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

192

2.03

6.04

1.1

pmol/l

9.1

12.1

—

(3000012) Reticulocyte production index

959

0.59

5.99

1.3

1.5

—

(3013336) Amino acids [Identifier] in Serum or Plasma

4.21

5.98

2.6

2.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

160

2.13

5.98

1.7

1.5

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

256

1111

1.40

5.92

1.1

1.0

u/ml

0.2

0.5

2.55

137

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

142

547

1.58

5.88

1.2

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.63

5.86

1.3

1.4

—

(3027035) Albumin [Mass/time] in 24 hour Urine

107

2.39

5.83

1.3

mg/24h

453.9

229.3

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

134

2.22

5.82

1.2

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

277

1.82

5.78

1.1

1.2

—

(3036782) Glucose [Moles/volume] in Pleural fluid

313

1414

1.35

5.69

1.4

1.3

mmol/l

6.2

6.1

0.38

293

1308

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

2.81

5.66

1.2

1.3

56.0

15.8

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

140

2.17

5.63

2.5

mg/l

1.0

1.3

0.57

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

9.12

5.58

1.3

1.5

—

(3019174) dRVVT (LA screen)

110

2.32

5.51

1.2

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

150

596

1.53

5.47

1.1

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

2.80

5.46

1.6

ng/l

201.2

190.9

0.35

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.55

5.42

1.3

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

277

1239

1.36

5.39

2.7

2.1

—

(4133840)

122

464

1.60

5.37

1.2

—

(3025296) Carrot IgE Ab [Units/volume] in Serum

4.23

5.36

1.1

1.0

u/ml

3.3

0.1

—

(3035880) pH of Pleural fluid

186

779

1.45

5.28

1.3

1.2

—

(40759632) Porphyrins [Mass/mass] in Stool

8.11

5.28

1.1

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

270

1.78

5.15

3.8

5.0

u/l

86.0

53.7

0.38

108

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

597

2975

1.22

5.05

1.4

1.3

ug/l

3.5

4.0

0.56

532

2706

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

4.48

5.00

6.0

3.5

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

337

1.68

4.97

1.3

1.2

—

(3045462) Protein/Creatinine [Ratio] in Urine

136

2.10

4.93

3.7

6.8

g/mol

47.9

66.7

0.44

129

(3046904) Somatotropin [Units/volume] in Serum or Plasma

4.15

4.92

4.0

2.5

mu/l

1.6

0.01

(40768800) Prostate Pathology biopsy report

448

3389

0.80

4.90

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

129

2.12

4.84

1.2

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

125

2.14

4.84

1.3

1.1

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

226

998

1.38

4.82

1.2

1.3

u/l

15.6

14.5

0.19

209

943

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.38

4.74

1.1

1.0

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

998

5244

1.16

4.68

5.4

4.5

0.9

1.64

958

4875

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

4.86

4.66

1.5

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

115

2.17

4.66

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

270

1.74

4.65

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

270

1.74

4.65

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

270

1.74

4.65

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

270

1.74

4.65

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

239

1.78

4.62

1.3

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

104

2.22

4.58

3.5

2.1

15.9

14.7

0.08

(3023430) Cat dander IgE Ab [Units/volume] in Serum

521

2589

1.23

4.58

1.1

1.0

u/ml

4.0

5.8

1.75

216

1035

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

331

1561

1.29

4.55

1.5

27.2

31.8

1.73

246

963

(37019676) Renin [Units/volume] in Plasma --supine

4.39

4.55

1.1

1.0

mu/l

98.0

23.2

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

2.47

4.52

1.1

1.0

u/l

86.3

51.5

0.35

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.42

4.49

1.2

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.75

4.44

1.4

1.3

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.97

4.41

1.4

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

5.53

4.37

1.5

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

331

2555

0.79

4.37

1.3

mmol/l

6.9

7.0

0.16

222

1821

(40758292) HTLV I+II Ab panel - Serum

244

1.75

4.34

1.3

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.59

4.32

8.8

4.1

—

(3016031) Almond IgE Ab [Units/volume] in Serum

2.24

4.32

1.0

1.1

u/ml

0.6

1.1

0.65

(3017958) Strawberry IgE Ab [Units/volume] in Serum

3.22

4.28

1.0

u/ml

0.0

0.1

0.19

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

347

1663

1.27

4.24

1.1

iu/ml

3.3

2.0

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

4.78

4.20

1.0

1.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

175

760

1.40

4.18

1.1

u/ml

1.9

18.9

1.65

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.29

4.15

1.1

1.0

—

(3041184) Isoniazid [Presence] in Urine

5.07

4.04

3.5

2.0

—

(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma

3.51

4.03

1.0

1.3

pmol/l

290.4

686.3

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

679

0.61

4.01

6.4

6.5

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

679

0.61

4.01

3.2

—

(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count

9.73

3.98

3.6

8.0

11.1

3.8

—

(3013862) HLA-DP [Type]

3.04

3.94

1.0

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

999

5323

1.14

3.93

5.1

4.5

1.7

0.30

956

4954

(3044009) aPTT.lupus sensitive (LA screen)

128

2.00

3.93

1.2

1.1

—

(3004451) EKG impression Narrative

824

0.65

3.91

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

156

677

1.40

3.78

1.0

—

(3007456) Orange IgE Ab [Units/volume] in Serum

3.14

3.69

1.1

1.0

u/ml

0.0

0.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

357

1.55

3.66

1.3

1.2

ug/l

196.2

190.4

0.02

180

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

2.36

3.63

1.1

u/l

2.4

4.4

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

2.70

3.62

1.1

1.0

u/ml

0.1

0.4

—

(3007542) Rye IgE Ab [Units/volume] in Serum

2.31

3.62

1.0

u/ml

1.8

0.2

0.64

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

240

1.67

3.59

1.3

20.7

22.4

0.18

198

(3012565) Volume of 24 hour Urine

110

967

0.69

3.58

2.1

2.3

2083.7

2006.7

0.28

102

881

(40763590) HLA-DQ beta [Type]

2.95

3.57

1.0

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.43

3.57

1.5

u/l

0.2

0.3

—

(3007700) Barley IgE Ab [Units/volume] in Serum

2.43

3.57

1.0

u/ml

0.9

0.2

0.46

(3051101) Glucose [Moles/volume] in Cord blood

331

0.48

3.56

6.3

6.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

2.52

3.52

1.3

1.2

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

100

2.07

3.52

1.1

u/l

5.8

12.3

1.45

100

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

2.12

3.51

1.0

u/ml

0.4

0.7

0.23

(3020618) Glucose [Moles/volume] in Synovial fluid

2.81

3.49

1.1

mmol/l

5.5

4.9

0.22

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

3.15

3.47

7.7

9.3

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

109

2.01

3.47

1.3

1.1

—

(3009883) Potato IgE Ab [Units/volume] in Serum

4.34

3.47

1.0

u/ml

0.3

0.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.87

3.42

2.1

1.4

—

(46236302) HLA-C [Type] by High resolution typing

2.87

3.42

1.0

—

(40760409) HLA-A [Type] by High resolution

2.87

3.42

1.0

—

(40760410) HLA-B [Type] by High resolution

2.87

3.42

1.0

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

175

1.77

3.41

1.6

1.7

mg/l

1.7

1.8

0.28

143

(3044590) Delta aminolevulinate [Moles/volume] in Urine

6.95

3.40

1.0

1.1

umol/l

10.5

22.1

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

8.51

3.34

1.1

1.2

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.12

3.33

1.1

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

252

1203

1.28

3.28

1.4

nmol/l

29.6

33.0

1.12

230

1126

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

2.79

3.28

1.9

2.5

—

(3024869) Neuronal Ab [Presence] in Serum

205

1.69

3.27

1.1

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

3.15

3.26

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

134

1118

0.73

3.24

1.2

1.3

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

145

1195

0.74

3.24

1.7

1.4

umol/l

61.4

72.2

1.62

107

(3040151) Glucose [Moles/volume] in Capillary blood

271

2058

0.80

3.23

11.4

6.0

mmol/l

7.4

7.1

0.45

213

1698

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.46

3.21

1.0

1.1

u/l

227.2

569.7

0.77

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

130

1.87

3.19

1.1

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

306

1.55

3.19

1.1

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

2.72

3.14

1.1

1.0

u/ml

0.3

0.5

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

227

1077

1.28

3.12

4.0

3.3

u/ml

31.3

67.6

3.97

216

1070

(3022475) Manganese [Moles/volume] in Blood

101

1.99

3.12

1.3

—

(3026470) Cobalt [Mass/volume] in Blood

180

828

1.32

3.11

1.8

2.0

ug/l

3.6

3.5

0.07

161

738

(3006184) Hemoglobin [Mass/volume] in Capillary blood

729

3871

1.15

3.11

1.9

2.2

g/l

130.3

131.4

0.46

423

3019

(21494567) Legionella sp IgM Ab [Presence] in Serum

114

1.92

3.10

1.3

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

345

0.53

3.07

2.3

2.7

mmol/l

6.4

7.2

1.03

173

(3025577) Chromium [Mass/volume] in Blood

177

816

1.32

3.02

1.8

2.1

ug/l

2.2

2.3

0.18

142

708

(3022806) Fractional oxyhemoglobin in Capillary blood

336

2476

0.82

3.02

2.1

1.7

91.2

89.7

5.25

330

2436

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

3.32

3.01

1.0

1.3

—

(40768793) Breast Pathology biopsy report

668

3538

1.15

2.97

1.3

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.14

2.96

1.0

1.1

—

(3005570) Glucose [Moles/volume] in Urine

216

1031

1.28

2.87

1.9

1.7

—

7.8

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

121

532

1.38

2.83

1.4

52.3

63.0

2.45

101

449

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

6.08

2.81

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.34

2.80

1.3

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

213

1020

1.27

2.77

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

118

0.31

2.77

1.2

1.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

102

1.91

2.74

4.8

6.7

76.5

73.4

0.28

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

4.86

2.74

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

4.86

2.74

1.1

1.0

titre

1752.5

1547.0

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

2.43

2.73

1.1

1.0

u/ml

0.1

0.4

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

7.30

2.71

1.0

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

351

1779

1.20

2.71

1.4

mmol/l

12.3

11.7

0.59

176

288

(3001686) Cold agglutinin [Titer] in Serum or Plasma

217

1.60

2.70

1.6

1.2

titre

46.8

268.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

261

1.54

2.67

1.5

1.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

176

828

1.29

2.65

1.7

1.8

—

(3017181) Myelocytes/100 leukocytes in Blood

2162

12270

1.08

2.59

4.4

3.6

1.2

1.0

2.52

757

3277

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

3.38

2.58

1.5

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.98

2.57

1.1

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

560

3894

0.87

2.54

5.3

3.4

—

(3049233) Organic acids panel - Urine

4.05

2.39

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1117

6192

1.10

2.37

1.4

—

(4281824)

359

1849

1.18

2.37

1.2

1.1

—

(3034614) HLA Ag [Interpretation]

2.81

2.37

1.4

1.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

361

0.61

2.32

1.3

1.2

—

(3007919) Fasciola sp Ab [Titer] in Serum

2.91

2.30

1.0

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

105

1.80

2.26

1.3

1.2

—

(3000285) Sodium [Moles/volume] in Blood

170

1.61

2.25

1.2

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

142

1.67

2.24

1.4

1.2

—

(3002179) Metamyelocytes/100 leukocytes in Blood

1738

11326

0.93

2.23

4.2

3.5

0.6

0.18

479

2489

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.95

2.22

1.3

1.1

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

115

1.75

2.21

1.1

1.2

ug/l

113.8

112.4

0.02

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

200

1.55

2.19

1.0

1.1

—

(3022689) Creatine [Moles/volume] in Urine

315

1.43

2.16

1.4

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

260

1.47

2.15

1.4

1.2

—

(3019298) Eosinophils/100 leukocytes in Peritoneal fluid

2.34

2.14

2.0

1.2

0.4

0.6

0.46

(3002523) Influenza virus A Ag [Presence] in Specimen

599

3233

1.13

2.12

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

145

1.64

2.09

1.0

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

122

1.69

2.08

1.1

1.3

u/l

1092.1

73.7

0.46

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

3.87

2.07

1.3

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

598

3234

1.13

2.06

1.1

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.28

2.04

1.0

1.1

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

2.28

2.04

2.8

1.4

ug/l

159.1

130.1

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

435

1.34

1.97

1.4

29.5

21.7

1.53

395

(3032641) Amino acids panel - Urine

3.24

1.97

1.0

1.2

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.91

1.96

1.1

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.30

1.94

1.0

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

1.99

1.90

1.3

1.6

nmol/l

38.2

17.4

0.68

(44806420)

487

0.70

1.90

2.3

—

(3049242) von Willebrand panel - Platelet poor plasma

2.43

1.87

1.2

1.9

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.84

1.85

1.4

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

2.17

1.85

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

148

720

1.25

1.82

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

9418

55914

1.03

1.81

4.7

4.4

ug/l

2.8

3.0

0.24

8551

50395

(3029612) Listeria sp Ab [Titer] in Serum

2.74

1.81

1.6

1.2

—

(3001218) Citrate [Mass/time] in 24 hour Urine

2.64

1.81

1.0

1.3

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

115

546

1.28

1.74

1.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.85

1.73

1.9

2.0

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

2.53

1.68

1.1

1.2

nmol/24h

111.0

87.7

—

(3015350) Toxocara sp Ab [Presence] in Serum

3.04

1.67

1.0

—

(3047181) Lactate [Moles/volume] in Blood

756

4201

1.10

1.64

6.3

5.0

mmol/l

1.3

0.11

692

3611

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.03

1.59

1.1

1.2

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

1.72

1.59

1.0

1.1

u/ml

3.1

8.7

1.46

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.76

1.58

1.3

1.4

—

(3006567) Chloride [Moles/time] in 24 hour Urine

2.43

1.57

1.2

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

2.14

1.56

7.8

6.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

1.91

1.56

1.0

1.1

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

2.21

1.56

1.0

1.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

110

838

0.80

1.54

1.6

1.4

3.8

4.2

0.09

213

(3025159) Blasts/100 leukocytes in Blood

1763

11315

0.94

1.51

4.5

3.7

0.1

0.2

0.98

497

2723

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

435

0.73

1.47

1.1

1.2

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.34

1.46

1.2

1.1

2.2

2.4

—

(3018291) Platelet Ab [Presence] in Serum

2.23

1.46

1.2

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

343

1845

1.13

1.40

1.7

1.5

53.3

57.5

1.11

239

1151

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

301

1.33

1.39

2.2

2.8

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

218

1.39

1.0

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.00

1.37

0.0

2.3

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.45

1.36

1.4

1.2

1.4

—

(3013762) Body weight Measured

1.86

1.30

1.1

1.2

—

(3009992) Blasts/100 cells in Bone marrow

2.61

1.28

1.7

23.8

12.9

—

(3017569) Oxygen content in Arterial blood

106

523

1.23

1.25

1.8

2.3

—

(40762814) Titanium [Mass/volume] in Blood

192

1.39

1.24

2.2

2.4

ug/l

2.6

4.7

1.58

(3001019) Free T4 and TSH panel - Serum or Plasma

1878

10901

1.05

1.22

1.6

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.97

1.22

1.2

1.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

248

1322

1.14

1.21

1.3

1.2

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

2.76

1.19

1.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.64

1.18

1.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.72

1.18

9.6

3.8

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

7516

44761

1.03

1.17

4.1

3.9

22.7

21.9

4.44

3534

20649

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.42

1.16

2.6

2.1

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

2.11

1.15

1.0

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

301

1.29

1.14

1.2

mg/l

176.2

35.2

0.72

220

(3035933) Granulocytes/100 leukocytes in Blood

112

563

1.21

1.13

1.6

1.9

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

2.36

1.12

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

2.36

1.12

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

2.36

1.12

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

2.36

1.12

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

2.36

1.12

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

2.36

1.12

1.0

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

166

0.62

1.12

10.5

7.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

186

1.37

1.11

1.1

1.2

mmol/l

0.8

1.5

0.83

113

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.77

1.08

1.1

1.3

nmol/l

343.5

530.1

1.00

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.87

1.07

1.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.89

1.00

1.0

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

2.03

0.98

1.0

—

(4038314)

166

1.36

0.94

1.2

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

236

1.29

0.91

1.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.53

0.91

1.0

—

(3015183) Erythrocyte sedimentation rate

144

1007

0.87

0.90

1.2

—

(3002079) Sodium [Moles/time] in 24 hour Urine

1.95

0.90

1.1

1.0

mmol/24h

130.0

158.2

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

1.95

0.90

1.0

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

141

0.65

0.88

3.5

2.0

15.1

19.7

—

(3024316) Viscosity of Plasma

1.52

0.87

1.4

1.8

mpas

1.6

1.9

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

302

1670

1.10

0.86

1.6

mmol/l

8.0

7.5

1.59

165

939

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

458

1.20

0.86

1.1

1.2

18.3

20.9

0.12

(46235168) Fasting glucose [Moles/volume] in Blood

240

1.27

0.82

1.3

2.1

mmol/l

7.3

7.0

0.17

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.79

0.81

1.0

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

103

1.42

0.81

1.0

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

2.34

0.79

1.0

1.1

—

(3002853) Influenza virus B Ab [Titer] in Serum

2.34

0.79

1.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

259

1727

0.91

0.76

1.4

1.5

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

1.93

0.76

1.3

1.4

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

1.93

0.76

1.0

—

(3038515) Glucose [Moles/volume] in Venous blood

462

3003

0.93

0.73

4.2

2.9

mmol/l

7.5

7.7

0.74

455

2947

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.61

0.72

1.1

1.2

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

245

0.77

0.71

1.4

9.8

10.4

—

141

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

478

3092

0.94

0.67

1.2

—

(1616796) Gas panel - Central venous blood

692

3997

1.05

0.66

3.5

3.4

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

337

1.19

0.66

1.3

41.0

38.5

0.19

244

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

159

0.73

0.65

3.1

2.1

53.6

56.6

0.11

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

205

1.25

0.64

1.0

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

945

5512

1.04

0.62

1.5

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

1.39

0.61

2.6

3.8

—

0.0

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

449

2897

0.94

0.61

4.0

2.8

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

110

1.33

0.59

1.1

—

(3035060) Mercury [Moles/volume] in Blood

1.74

0.58

1.2

1.9

nmol/l

11.8

17.0

—

(40762887) Creatinine [Moles/volume] in Blood

1.74

0.58

1.7

1.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

105

1.33

0.58

5.6

4.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

501

0.86

0.58

1.8

1.9

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

225

1.22

0.57

1.6

1.5

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

1.66

0.56

1.0

—

(44786800) Granulocytes/100 leukocytes in Body fluid

187

0.78

0.53

1.2

1.4

32.0

24.1

0.44

142

(3047352) Trisomy 18 risk [Likelihood] in Fetus

922

5399

1.04

0.53

1.4

1.5

—

(3021901) Oxygen saturation in Capillary blood

482

2785

1.05

0.51

2.9

2.7

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

240

1358

1.07

0.49

1.2

1.3

g/l

1.5

0.08

(3052592) Norovirus Ag [Presence] in Stool

247

1.18

0.48

1.4

1.3

—

(3005033) Fetal Nuchal fold Thickness US

918

5390

1.04

0.48

1.4

1.5

—

(36303858) Crystals [Presence] in Urine

1.47

0.47

1.4

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

236

0.82

0.46

1.8

3.3

—

(3007916) DNA double strand Ab [Titer] in Serum

126

1.25

0.46

1.6

1.3

titre

86.7

59.6

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

143

1.23

0.45

1.1

u/l

24.1

19.7

0.63

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.64

0.44

1.0

g/l

160.5

167.1

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.43

0.43

1.0

1.1

—

(3014171) Thiocyanate [Moles/volume] in Serum or Plasma

0.00

0.43

0.0

1.4

—

140.4

—

(36304079) Mucus [Presence] in Urine sediment

0.00

0.42

0.0

1.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.42

0.42

1.2

1.0

mmol/l

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

274

1.15

0.41

8.1

6.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

114

632

1.10

0.41

4.1

3.6

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

105

0.75

0.40

1.1

1.5

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

218

0.84

0.39

1.1

1.2

mmol/l

21.0

20.5

0.38

178

(3016228) CD19 cells/100 cells in Blood

102

565

1.10

0.38

2.0

9.0

8.3

0.25

554

(40758358) Immune stain study

1.39

0.38

1.0

—

(3008037) Lactate [Moles/volume] in Venous blood

491

3104

0.96

0.37

4.1

2.8

mmol/l

1.5

1.6

1.28

482

3041

(3044242) Glucose [Moles/volume] in Arterial blood

613

0.91

0.35

1.5

2.1

—

(3006598) pH of Arterial cord blood

143

0.81

0.35

1.1

1.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

305

1768

1.05

0.34

3.0

2.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1966

12161

0.98

0.33

1.5

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.26

0.32

1.1

1.0

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

140

0.82

0.30

1.1

iu/ml

19.8

15.8

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

271

1722

0.96

0.29

1.5

1.3

pmol/l

61.4

138.1

0.80

483

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

139

0.83

0.28

1.0

1.1

—

(3004959) Base excess in Arterial cord blood by calculation

139

0.83

0.28

1.1

1.0

mmol/l

-2.7

-2.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

216

0.87

0.27

1.3

1.5

—

(3042631) Mycobacterium sp identified in Specimen

329

2076

0.96

0.26

3.0

2.3

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.24

0.26

1.3

1.4

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

212

1231

1.05

0.25

2.2

1.7

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

1.38

0.24

1.2

1.1

—

(3001729) Color of Synovial fluid

142

0.86

0.23

1.2

1.6

—

(3004775) Volume in Urine collected for unspecified duration

190

1207

0.96

0.22

2.5

2.0

680.9

700.0

0.27

153

741

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

295

1.09

0.22

2.6

2.3

mg/l

61.8

35.0

0.42

(21494814) CD8 cells/100 lymphocytes in Specimen

554

1.06

0.22

2.0

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

0.21

0.0

1.3

—

1.4

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

205

0.89

0.21

6.5

6.7

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

5364

32835

0.99

0.21

2.7

2.8

ug/l

0.7

0.8

15.40

3832

20255

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

268

0.91

0.21

5.3

4.8

ug/min

49.3

50.4

0.04

219

(3009677) Dengue virus Ab [Presence] in Serum

0.79

0.20

1.4

1.1

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

116

669

1.05

0.20

1.2

45.9

67.6

1.57

(3010937) Rubella virus Ab [Presence] in Serum

117

1.14

0.19

1.2

1.1

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.18

0.18

6.0

5.7

mmol/l

0.3

0.2

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

376

1.07

0.17

2.8

2.2

ng/l

125.1

95.9

0.68

176

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

1.22

0.17

1.4

1.1

mg/l

0.0

0.8

0.52

(3041806) Other cells [#/volume] in Blood by Manual count

163

1029

0.96

0.17

1.7

1.4

—

(3029396) Erythrocyte agglutination [Presence] in Blood

107

622

1.05

0.15

3.1

3.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

203

1.08

0.13

2.4

2.6

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

328

1.06

0.12

8.3

6.3

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

252

0.94

0.10

1.1

1.2

mmol/l

2.1

1.7

0.43

145

(3021162) Amylase [Enzymatic activity/volume] in Specimen

241

1.06

0.10

2.3

2.9

u/l

600.3

1622.7

1.09

221

(3013466) aPTT in Blood by Coagulation assay

1.11

0.10

1.1

35.2

37.9

0.96

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

1.09

0.10

1.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

204

1215

1.02

0.09

1.0

—

(3003577) Lead [Moles/volume] in Blood

153

1.07

0.09

1.3

1.6

umol/l

0.1

0.2

—

(3011325) HIV 1+2 Ab [Presence] in Serum

107

0.91

0.09

1.1

1.0

—

(40763791) Oxygen content in Venous blood by calculation

1.15

0.08

4.5

6.2

ml/dl

11.2

11.9

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.11

0.08

1.0

—

(40768795) Lymph node Pathology biopsy report

289

1773

0.99

0.04

1.2

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

133

1.05

0.04

2.5

2.4

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

507

1.02

0.04

1.5

1.4

3.3

2.5

0.31

432

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

122

0.95

0.04

1.1

1.0

—

(3016750) Collection duration of Urine

142

874

0.99

0.03

2.4

1.9

min

503.8

502.3

0.07

126

587

(3021440) Promyelocytes/100 leukocytes in Blood

1935

11784

1.00

0.02

4.5

3.7

0.3

0.1

1.31

622

3059

(3018572) Chloride [Moles/volume] in Blood

487

2973

1.00

0.02

7.8

5.8

mmol/l

105.1

0.05

455

2642

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.09

0.02

1.2

1.1

mmol/l

8.1

8.8

—

(3039000) Anion gap in Blood

487

2972

1.00

0.02

7.8

5.8

mmol/l

11.0

11.3

1.64

455

2641

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

577

1.01

0.02

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.99

0.00

1.1

1.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

420

1.00

0.00

1.2

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

0.0

1.0

—

18.0

—

(3035963) Corticotropin [Moles/volume] in Plasma

0.00

0.0

1.0

—

12.5

—

(3039621) Maximum lysis.intrinsic coagulation system activated.heparin insensitive [Length fraction] in Blood by Rotational TEG

0.00

0.0

2.8

—

3.4

—

(3020071) Venlafaxine [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

1.01

0.00

2.0

1.2

mmol/24h

1.7

2.1

—

(3022670) pH of Venous cord blood

0.89

0.00

1.0

—

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: Z21_EXAM_OBSER_OTH_REASO – Examination and observation for other reasons

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Examination and observation for other reasons

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Examination and observation for other reasons (Z21_EXAM_OBSER_OTH_REASO)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints